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Abstract
Bacterial type I modular polyketide synthases (PKS) are large multifunctional
enzyme systems responsible for the biosynthesis of complex polyketide natural
products such as erythromycin, pikromycin, and borrelidin. Type I systems are
comprised of a loading module which generally selects an appropriate acyl group
starter unit, and multiple discrete extension modules, responsible for each single round
of acyl group incorporation into the final polyketide core structure. These modules
can exist naturally as either single discrete polypeptides, such as modules 5 and 6 from
the pikromycin PKS (PikA3 and PikA4 respectively), or as multimodular polypeptides
fused together by short intrapolypeptide linkers such as the loading module and the
first and second extension modules of the erythromycin and pikromycin PKSs
(DEBS1 and PikAI respectively). While short peptide linkers between modules on the
same polypeptide facilitate the transfer of polyketide intermediates from one module
to the next via their close proximity to one another, docking domains found at the Cterminus of one module and the N-terminus of the next subsequent module facilitate
the needed protein-protein interactions for the passage of biosynthetic intermediates
between modules on separate polypeptides.
The ability to utilize docking domains in place of intrapolypeptide linkers was
explored in the pikromycin and erythromycin PKSs by dissecting the tri-modular
PikAI and DEBS1 polypeptides with matched docking domains. It has been shown
that PikAI can be separated into two proteins at either of these linkers, only when
matched pairs of docking domains from a heterologous modular phoslactomycin PKS
are used in place of the intrapolypeptide linker. In both cases the yields of pikromycin
i

produced by the S. venezuelae host mutant, which is a PikAI deletion strain were 50%
of that of an S. venezuelae strain expressing the native trimodular PikAI.
Additionally, expression of module 2 as a monomodular protein fused to a
heterologous N-terminal docking domain was also observed to give almost a 10-fold
improvement in the in vivo generation of pikromycin from a synthetic diketide
intermediate.
The utilization of docking domains to separate linked modules was also
demonstrated in the erythromycin PKS. Expression of the first protein involved in
erythromycin biosynthesis (DEBS1) with the DEBS thioesterase fused to the Cterminal (DEBS1-TE) in S. venezuelae results in the production of triketide lactone
products. Separation of DEBS1-TE resulted in 50% triketide lactone production,
consistent with the observations in the pikromycin system. Published work has shown
that the DEBS loading module has relaxed substrate specificity, and is capable of
incorporating acetate, butyrate and isobutyrate in addition to the normally observed
propionate starter unit, which typically predominates. However, in the current study
when the DEBS loading module is separated from module 1 with matched docking
domains, a dramatic shift in the starter unit, favoring the isobutyrate derived tri-ketide
lactone is observed. This apparent shift in starter unit preference for a dissected PKS
system has resulted in insights into the kinetics of acyl group loading, off loading, as
well as the hydrolysis and transfer from the AT to ACP domains.
In addition to the separation of multimodular PKS polypeptides with docking
domains, it has also been shown that the individual catalytic domains of single discrete
module, BorA5 from the borrelidin PKS can be expressed as stand alone proteins
ii

while retaining catalytic functionality in vitro. This work has provided a basis for
future studies of this module, which has been proposed to function iteratively,
catalyzing three rounds of chain elongation.
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1. Introduction

1.1 General background on streptomyces and secondary metabolites
The largest genus of the bacterial order Actinomycetales is streptomyces with
over 500 species having been reported and described (1, 2). Streptomyces are grampositive filamentous bacteria with genomes characteristically high in G+C content (3).
Streptomyces species are found in virtually all soil environments worldwide and are
the producers of chemical metabolites called geosmins that are responsible for the
characteristic earthly smell that is associated with soil (4).
Microbial organisms have long been used as a source of active pharmaceutical
therapeutic agents. Organisms ranging from filamentous fungi, actinomycetes,
myxobacteria, and cyanobacteria are some of the most industrious producers of the
over 20,000 reported secondary metabolites (5) which are also referred to as microbial
natural products. Secondary metabolites, whether they are from microbial or in many
cases plant sources, are not required for primary growth of the organism but
presumably offer a competitive advantage in potentially harsh and competitive natural
environments. Many of these microbial secondary metabolites are defined as
antibiotics, which are compounds that inhibit the growth of other microbes.
Actinomycetes are responsible for the production of over two thirds of the currently
known antibiotics. Although many of the bacteria-derived natural products were
initially discovered based on their antibacterial, antifungal, antiviral and antiparasitic
activities, many have been developed for other applications. Compounds such as
1

epothilone A, tubulysin A, and rapamycin, (Figure 1) are currently better known and
used for their anticancer and immunosuppressant activities.

Figure 1. Examples of anticancer and immunosuppressant microbial natural
products.
1.2. Polyketide and nonribosomal peptide natural products
Generally, bacterial-derived natural products have been categorized according
to their biosynthesis as either polyketide or non-ribosomal peptide natural products
(6). Polyketide, nonribsomal and mixed polyketide-non-ribosomal natural products
are a structurally rich and diverse class of compounds with an enormous range of
medically important applications (7). Examples of polyketides include the antibiotics
2

erythromycin, tylosin, tetracyclines, pikromycin, the antitumor agent doxorubicin and
the cholesterol lowering agent lovastatin (Figure 2). These compounds are
biosynthesized by large organized sets of enzymes known as polyketide synthases
(PKSs) in a manner resembling fatty acid biosynthesis (8), where simple acylcoenzyme A (CoA) building blocks such as acetyl, propionyl, malonyl,
methylmalonyl, and ethylmalonyl CoAs are elongated in a head to tail manner into the
final polyketide structure. Natural products with nonribosomal peptide synthase
origins such as the siderophores yersinibactin, enterobactin and coelichelin (Figure 3)
are biosynthesized in a similar manner to polyketides by multimodular biocatalysts,
except that the building block monomers are amino acids instead of acyl-CoAs. In
addition to the 20-proteinogenic amino acids many non-proteinogenic amino acids
have also been shown to be utilized; there have been over 400 reported monomers
used for nonribosomal peptide building blocks (9, 10).

3

Figure 2. Examples of polyketide natural products.

4

Figure 3. Examples of non-ribosomal peptide natural products.

5

1.3. Polyketide synthases and its relationship to fatty acid synthases
Polyketide natural products represent a large array of structurally diverse and
medically important compounds. The enzyme systems which are responsible for their
production are comprised of a combination of catalytic domains with specific
dedicated functions which together are defined as polyketide synthases (PKSs) (1115). PKSs are part of secondary metabolic pathways, meaning that expression of the
genes likely occurs only under certain environmental conditions (16, 17). Much of the
basic information that is known about polyketide biosynthesis has been derived from
the mechanistically similar fatty acid synthase (FAS) from primary biosynthetic
pathways (17, 18). Both Type I FAS and PKS systems contain specific protein
domains (19, 20) that are responsible for the production of their respective fatty acid
and polyketide products, these specific domains along with their functional roles are
summarized in Figure 4. In the general scheme that is followed by both FAS and PKS
biosynthesis, each round of elongation involves a decarboxylative condensation
between a ketosynthase (KS) domain bound intermediate and an acyl carrier protein
(ACP)/CoA bound extender unit. In FAS systems the keto group on the β carbon is
fully reduced before the next round of elongation or chain termination. In contrast,
PKS systems control the level of keto group reduction by selectively reducing only at
certain positions to either a hydroxyl or alkene or full alkane. This selective control of
reduction at specific positions of the polyketide structure helps dictate the rich
chemical diversity, which these compounds naturally display.

6

Figure 4. Generic reaction scheme for both fatty acid and polyketide
biosynthesis. Each round of elongation involves the decarboxylative condensation of
the KS bound product of the preceding round with either the CoA or ACP bound
extender unit. Additional processing can occur involving a combination of
ketoreduction (KR), dehydration (DH) and enoyl reduction (ER) to generate the final
fatty acid or polyketide product. Figured modified from (21).
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FAS systems are classified as either types I or II, depending on the
configuration of the functional domains. FASs are classified as either type I if the
catalytic domains are covalently linked on the same polypeptide as observed in
vertebrate systems or type II if each domain is a discrete protein as found in bacteria.
FASs synthesize long fatty acid chains via successive rounds of iterative
decarboxylative condensation of short carbon groups from acyl-CoAs in combination
with ketoreduction, dehydration and enoyl reduction steps to produce the final fatty
acid product (Figure 4). Typically acetyl CoA is incorporated as the starter unit and
malonyl CoA the source of the extender units however there have been reported
examples of isobutyryl and methyl-butyryl CoA being incorporated as well, generating
branched chain fatty acids (22).

1.4. Types of polyketide synthases
PKSs are complex protein systems which have been generally classified into
three categories, type I, II and III (Figure 5). This classification is system is primarily
based on the mechanistic manner in which the protein machinery incorporates the
extender units into the polyketide product and whether the functional domains, which
are homologous to those of the FAS enzyme system, operate in a discrete or iterative
fashion.

8

Figure 5a. Schematic example and organization of a type I modular PKS

9

b) Type II PKS (iterative)

c) Type III PKS (iterative)

Figure 5b-c. Schematic examples and organization of Type II and III PKS
AT – Acyl transferase, ACP – Acyl carrier protein, DH – Dehydratase, ER – Enoyl
reductase, KR- Ketoreductase, KS – Ketoreductase, TE – Thioesterase. Figure
adapted from (23).
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The linear description of type I modular PKSs resemble that of animal type I
FASs in both the domain organization at the primary sequence level as well as the
sequence of chemical reactions (24, 23). However, there is one distinction between
animal FASs and type I polyketide biosynthesis, which is the iterative nature of fatty
acid production, where the same catalytic domains are used repeatedly to produce
products of the proper length. In type I modular PKS systems large multifunctional
enzyme complexes containing discrete modules are almost always responsible for
each single round of polyketide chain elongation (11). A module is defined as a set of
enzymatic domains required to carry out a single round of chain elongation.
Contained within each module there are discrete sets of catalytic domains
responsible for that particular round of chain elongation and any tailoring activities.
At minimum each module contains an acyltransferase (AT) domain responsible for
selecting the extender acyl substrate and priming the cognate acyl carrier protein
(ACP) domain that holds the growing polyketide chain. The ketosynthase (KS)
domain within the module is charged with accepting the polyketide intermediate from
the preceding module’s ACP domain and the catalyzation of a Claisen-like
condensation between the ACP bound extender acyl substrate and the growing chain.
Some PKS modules contain a variety of tailoring domains (KR, ER, DH) responsible
for catalyzing keto group reduction, enoyl group reduction, and dehydration activities
respectively.
Type II PKS (Figure 5b) are iterative acting complexes of discrete proteins
with specific functionalities (25). These systems catalyze iterative decarboxylative
condensation reactions usually with malonyl CoA by utilizing two KS-like condensing
11

enzymes domains. This, along with a discrete ACP where the growing polyketide
chain is covalently bound, and a variety of tailoring domains [KR, CYC (cyclase),
aromatase (ARO)] direct the production of the final polyketide product (21). The third
type of PKS, type III is characterized by the use of a single multifunctional KS-like
enzyme active site with the capacity to incorporate acyl CoA extender units and
perform all the necessary steps to assemble the polyketide backbone of the defined and
proper length (21, 26).

1.5. Protein domain interactions required for polyketide production
An interesting aspect of type I modular PKSs involves the ordered arrangement
of the modules. The polyketide chain elongation process is initiated by the priming of
a loading module or loading domain (LD) with the appropriate starter unit, which is
elongated by each subsequent module with either typically malonyl or methylmalonyl
via their respective CoA thioesters into the final polyketide product. In many PKSs,
multiple modules (typically two to six) can be housed on a single polypeptide. There
are also many PKSs where several or even all of the modules are contained on
separate polypeptides.
Perhaps the simplest, yet imperative question about polyketide biosynthesis
involves the specificity and fidelity of processing biosynthetic intermediates. Whether
the next subsequent module in polyketide biosynthesis is on the same polypeptide or
separate polypeptides, an efficient and faithful passage of intermediates is vital. The
proper channeling of polyketide biosynthetic intermediates involves specific proteinprotein interactions between the individual domains of a single module in order to
12

prime, extend and tailor the intermediate properly. Additionally the appropriate
module-to-module interactions are required to properly and efficiently transfer the
growing polyketide backbone from the ACP of one module to the correct KS of the
subsequent module. The ACP domain plays a vital role in this process; it is required
to interact with all the individual domains of its own module as well as the KS of the
subsequent module. During each round of elongation, the growing polyketide
backbone is bound to the ACP domain via a prosthetic phosphopantetheine group that
is the result of a post translational modification of the protein at a specific serine
residue. The phosphopantetheine group has been described to act like a swinging arm,
capable of a variety of activities; a) accepting the elongation acyl group from the AT,
b) interacting with the KS to facilitate condensation, c) presenting the intermediate
group to the various reduction domains (KR, DH, ER) described above that maybe
present on the module and d) facilitating passage of the intermediate to the KS of the
subsequent module for elongation (Figure 6).

13

Figure 6. Polyketide synthase domain interactions. ACP bound intermediates must
be able to efficiently interact with all the domains of its cognate module as well as the
subsequent KS domain. Figure adapted from (24).
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The ability of the ACP domain to efficiently interact with the KS and AT
domains of its own module is vital for polyketide biosynthesis. While ACP
interactions with the reduction domains appear to be dictated by proximity of the
domains to the ACP bound intermediate (24), its interactions with the KS and AT
appear to be more structured. Specifically matched recognition motifs are likely to be
involved in the KS to ACP and AT to ACP interactions, in addition the ACP domain
likely possesses inherent conformational dynamics that play an important role in these
interactions (27-29).
The substrate specificity of the accepting KS domain as well as the
conformation of the donating ACP play crucial roles for the efficiency of polyketide
chain transfer. In type I modular PKS systems, transfer of the growing native
polyketide chain between ACP and KS domains seems to occur efficiently whether
modules are linked together on the same polypeptide or if they are disconnected on
separate polypeptides. Presumably, when modules are on the same polypeptide
connected with a short linker sequence (30) the transfer is facile, as the donating ACP
and accepting KS are close together. For sequential modules separated on different
polypeptides, structural evidence has shown that key interactions between amino acids
at the C-terminal of the ACP and the N-terminal of the KS forming important docking
interactions between the two modules (31).

15

1.6. Linkers and Docking Domains
PKS modules that are housed on the same polypeptide are separated by a short
intrapolypeptide linker (i.e. between module 1 and 2 of the Pik PKS) (Figure 5a), that
is typically about 20-30 amino acids long and is responsible for linking modules
within multimodular polypeptides (31, 32). Generally these intrapolypeptide linkers
are not conserved at either the nucleic or amino acid level but appear necessary for
polyketide production process. Conversely, much longer docking domains (DDs,
~100 amino acids) are found at the C-terminus of ACP domains, and the N-terminus
of KS domains between both monomodular and multimodular PKS polypeptides such
as that between module 2 and 3 of the Pik PKS (Figure 5a). Both linkers and DDs
function in mediating the transfer of polyketide intermediate from the ACP of one
module to the KS of the subsequent module (32-34) (Figure 7a-b). The term DD has
been defined as the stretch of amino acids at the C-terminus of a PKS protein after the
end of ACP homology, along with the amino acids found at the N-terminus of the next
protein before the beginning of KS homology. Together these peptide regions or DDs
are vital to the passage of the growing polyketide chain from one module to the next
neighboring module on a separate polypeptide.

16

Figure 7. Passage of polyketide intermediates between rounds of elongation. The
passage of intermediates between ACP and KS domains can be mediated by either (a)
short intraprotein linkers or (b) docking domains. Iterative functionality (c) entails the
passage of an ACP bound intermediate to the KS of the same module. Figure adapted
from (24).
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These docking domains (DD) have been shown to be essential in promoting
the appropriate protein-protein, and thus module-module, interactions required for the
biosynthetic processes (35, 33, 36-38). Based on amino acid sequence analysis, a
recent method for categorizing PKS DDs into subclasses has been published (39).
Thattai and co-workers have defined specific amino acid interactions between head
(ACP bound) and tail (KS bound) DD pairs that have been generally categorized as
H1-T1, H2-T2, or H3-T3. These interactions are proposed to give the DD pair a
specific affinity for one another that facilitates the proper and efficient passage of
biosynthetic intermediates.
Both NMR and x-ray crystallographic structural models of the DD interactions
for DEBS2/DEBS3 (32) (Figure 8) and PikAIII/PikAIV (40) junctions respectively
have been reported; these two sets of docking domain fall into the category of H1-T1
and H2-T2 respectively. Both of these models depict the DD interactions as being
primarily determined by two sets of the four alpha helix interactions. Dimerization
elements are generated by two four alpha helix bundles formed by the two C-terminal
ACP bound DDs of the PKS homodimer, while a second is formed by the coiled-coil
of the N-terminal KS which forms a helix-bundle dimerization element with two
helices from the C-terminal ACP bound DD. These interactions play a critical role in
both the stabilization of the PKS homodimer and the docking interactions of the Cterminal ACP bound domain with the N-terminal DD of the subsequent KS (32, 40).

18

Figure 8. Structural basis for docking in modular PKSs. NMR solution structure of
the DEBS 2/3 docking domain complex. The dimeric C-terminal ACP DD is shown in
blue and yellow (three helices), while the dimeric N-terminal KS DD is shown in
green and orange. Two dimerization elements are present, an intertwined four a-helical
bundle formed by helices 1, 1’, 2, and 2’, and a coiled-coil motif formed by the Nterminal docking domain. Docking between the two domains, results in formation of a
second four α-helical bundle, as indicated. The linker region between helices 2 and 3
is highly mobile, and therefore is represented as a dashed line in the structure.
Reproduced with permission from (22).
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1.7. Genetic Engineering of PKS pathways
Despite the vast structural diversity that exists with naturally occurring
polyketide natural products, there has been a strong focus and desire to generate
compounds with even more structural diversity than what nature has already supplied.
Approaches that have been successfully used to generate novel natural product
inspired compounds include semisynthetic and total synthetic routes using the natural
product scaffold. Efforts to generate new compounds using these synthetic routes
based on natural product scaffolds have resulted in many natural product inspired
compounds that are currently used in pharmaceutical applications (7).
When the linear description of modular type I PKSs was first reported (11, 13)
these enzyme systems seemed to be an excellent tool for generating compounds with
rich chemical diversity via combinatorial and genetic engineering methods (41-43).
Based on the assembly line model for these systems a variety of strategies have been
used in attempts to reprogram these pathways at the DNA level, creating hybrid PKS
proteins capable of processing a variety of substrates, thus creating engineered natural
products. Common approaches such as the inactivation/deletion of individual catalytic
domains (AT, ACP, KR, DH, ER) or the insertion of new ones within an intact
module have generated over 200 novel structures (44), however often times only trace
levels of the new product is produced if any at all from the genetically engineered
hybrid systems. The low levels of production come from compatibility issues, which
limits the transfer of the growing polyketide chain in a hybrid system, from the
donating ACP to the sequential KS domain. Indeed, in model systems it has been
20

shown that when the non-native KS domain for the donating ACP is replaced with the
naturally accepting KS domain, production of a polyketide product can be restored
(45). This evidence shows that there are intrinsic interactions between naturally
sequential modules (ACP and KS domains), which are important for polyketide
biosynthesis.
Due to the intricacies involved with forming the proper domain-domain
interactions within an engineered single module, there has also been an effort to
generate hybrid PKS pathways by using complete and intact modules as the building
blocks, versus individual catalytic domains, along with matched docking domain pairs
to generate the required module-module interactions (44). The rationale for this
approach has been built on the fact that domains contained within a single module are
already optimized to interact with one another efficiently, which alleviates the need to
engineer the proper domain interactions. However with this approach there are still
considerations that must be met to form efficient hybrid systems, such as a) the
modules as a whole which are being used as the building blocks must exhibit some
substrate flexibility capable of processing a variety of intermediates, and b) there must
be the proper communication/interactions between heterologous modules for efficient
passage of ACP bound intermediates to the subsequent KS of the next module.

1.8. Iterative PKS modules and substrate flexibility
PKS modules such as BorA5 from the borrelidin (46) and AurA from the
aureothin (47) PKSs differ from typical PKS modules in that they are proposed to
function in an iterative fashion. While the mechanism for iteration is unknown, the
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idea of a module functioning iteratively suggests that there is inherent substrate
flexibility, something that allows for a variety of substrates to be processed efficiently.
For iterative PKS modules a variety of intramodular events must take place. In
addition to the normal reduction and dehydration processing which the ACP bound
intermediate must undergo (when these domains are present on the module), the ACP
bound intermediates must also be passed back to the KS of the same module (Figure
7c) to undergo further elongations before passage to the subsequent KS of the next
module, which presumably has specificity for a polyketide chain of a certain length to
prevent premature transfer. This is an interesting phenomenon for modular PKS
systems, where it is usually accepted that either linkers or DDs are required for
passage of the growing polyketide chain between ACP and KS domains (Figure 7a-b);
where the presence of intrapolypeptide linkers results in the close proximity of the
ACP donor and KS acceptor and DDs aid in the specific recognition of the proper
ACP – KS interactions (32-34, 48). This means that the KS domains of the iterative
modules are capable of being primed by the ACP of its own module multiple times
with polyketide chains of differing lengths. It is this built in flexibility that offers the
possibility of generating more efficient hybrid systems, capable of possibly generating
a variety of polyketide intermediates.

1.9. Macrolide antibiotics
Polyketide natural products such as pikromycin, methymycin, erythromycin,
azithromycin, and roxithromycin are classified as macrolides because of their large
macrocyclic lactone core structure, to which a deoxysugar is attached. Pikromycin
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(Figure 9) was the first isolated macrolide antibiotic reported in 1951 and methymycin
was the first to have its structure fully elucidated. Macrolide antibiotics exert their
biological activity by binding to the 50S subunit of the bacterial ribosome, blocking
the translocation of peptidyl tRNA and therefore inhibiting protein synthesis (49).

Figure 9. Structures of the pikromycin series of antibiotics
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1.10. Introduction to pikromycin and erythromycin PKS
Much of the knowledge of polyketide biosynthesis has come from the wellstudied model system for type I PKS biosynthesis: 6-deoxyerythronolide B (DEBS)
PKS (Figure 10a), which produces the aglycone precursor for the antibiotic
erythromycin B from Saccharopolyspora erythraea NRRL 2338. Genetic sequence
information from DEBS along with the homology that PKSs share with FASs, have
allowed for structural dissection (12) and biochemical investigation of the modular
subunits that comprise this PKS pathway. This well studied model system has laid
much of the groundwork for biochemical, structural, and genetic engineering efforts
for other type I modular PKS systems (50).

1.10.1. Pikromycin PKS
The pikromycin and erythromycin PKSs are similar in that they both contain a
LD and six extension modules, the first polypeptide houses the LD along with the first
two extension modules, and a propionyl acyl group is passed from the LD to the KS of
the first extension module (in the Pik system methylmalonyl CoA is initially loaded
and decarboxylated to yield the propionyl group, while in the DEBS system propionyl
CoA is loaded directly). Despite the similarities in modular organization, these two
PKS systems produce different compounds, as a result of tailoring domain placement
within the modules, which mediates the degree of reduction during each round of
elongation and the activities of post PKS enzymes.
The pikromycin/methymycin (Pik) PKS from Streptomyces venezuelae ATCC
15439 produces four members of the pikromycin series of macrolides, methymycin,
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neomethymycin, pikromycin and narbomycin (Figure 9). The Pik PKS is unique in its
ability to produce both 12- and 14- member macrolactones. This is accomplished via
thioesterease activity after either five or six rounds of chain elongation, followed by
cyclization. The biosynthetic gene cluster encoding the Pik PKS responsible for
biosynthesis of these macrolides was cloned and reported in 1998 (51). This gene
cluster consists of 18 genes that are divided into five loci based on their biosynthetic
function. PikA contains the PKS genes, pikB is responsible for desoamine
biosynthesis, pikC encodes a cytochrome P450 hydroxylase, pikD encodes as a
transcriptional activator regulating the biosynthetic pathway, and pikR is a resistance
gene to yield self- protection from the produced antibiotics (52).
The six Pik extension modules along with the LD and thioesterase domain are
housed on four separate polypeptides (Figure 5a) that are responsible for the
biosynthesis of both 12 and 14-membered ring macrolides 10-deoxymethnolide and
narbonolide. Additional modification by a glycosyl transferase results in glycosylated
macrolides, followed by hydroxylation results in the final corresponding antibiotics
methymycin and pikromycin.

1.10.2. DEBS PKS
The DEBS PKS (Figure 9a) from Saccharopolyspora erythraea is remarkably
similar to the Pik system. However in the DEBS system the six extension modules are
housed on three discrete polypeptides (versus four in the case of Pik). DEBS1 is
similar to PikAI, in that it is a trimodular protein, containing the loading domain (LD)
and the first two extension modules on the same polypeptide.
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Although the natural starter unit for erythromycin biosynthesis is propionyl
CoA, DEBS LD displays a substantial amount of substrate flexibility. There have
been several examples both in vitro and in vivo where acetyl, butyryl, and isobutyryl
CoA in addition to its natural starter unit, propionyl CoA have been successfully
processed by the erythromycin PKS enzymes (53-56). Previously reported in vitro
and in vivo engineering work on the DEBS PKS (54, 55, 57) has shown that fusion of
the DEBS TE domain to the C-terminal of DEBS1 yields a catalytically fusion protein
DEBS1-TE (Figure 10b). This fusion protein is capable of loading a starter unit and
processing two rounds of chain elongation before the terminal TE domain catalyzes
release and cyclization of the predicted triketide lactone polyketide product.
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a) Erythromycin / DEBS PKS

b) DEBS1-TE

Figure 10. Erythromycin PKS. a) Modular organization of the erythromycin PKS. b)
DEBS1 – TE fusion protein functions to generate triketide lactone products.
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1.11. Research objectives
In many PKSs, multiple modules (typically two to six) can be housed on a
single polypeptide. There are also many PKSs where several or even all of the
modules are contained on separate polypeptides. The six extension modules of the
pikromycin PKS are housed on a combination of multimodular (PikAI and PikAII)
and monomodular (PikAIII and PikAIV) polypeptides (Figure 5a). In contrast the six
extension modules of DEBS, are all housed on three bimodular polypeptides (Figure
10a) (11-13).
The overall goal of this work involves development of strategies to generate
efficient hybrid PKS systems. One such strategy, involves the utilization of matched
DDs to pair modules from heterologous systems together. However, before DDs can
be utilized, the first step in this approach requires that the specific impact on
polyketide production when matched docking domains pairs are substituted for the
natural intrapolypeptide linkers be examined. The impact on the efficiency of
polyketide production will be examined in both the pikromycin (PikAI) and DEBS
(DEBS1-TE) PKSs when heterologous DDs have been substituted for the native linker
peptides between the modules of these multimodular polypeptides. This work will
provide insight into the feasibility of using matched DD pairs to mix and match
modules from heterologous PKS systems by determining the relative impact on the
overall polyketide production when multimodular PKS proteins are dissected using
DD pairs.
A second strategy for generating hybrid PKSs capable of producing novel
products involves utilizing iterative PKS modules. By examining the substrate
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flexibility of BorA5, an iterative module from the borrelidin PKS to utilize a variety of
substrates it will also be possible to use this module’s intrinsic processing flexibility as
a tool to generate efficient hybrid PKS systems. In the long term, utilizing the implicit
broad substrate specificity that iterative modules such as BorA5 exhibits may make it
amenable to pair with heterologous modules by utilizing the specificity and
exclusiveness that matched DD pairs offer, in forming the necessary interactions for
the passage of polyketide biosynthetic intermediates.

Specific goals:
Pikromycin PKS
1. To determine whether the trimodular PikA1 polypeptide can be functionally
dissected into two separate polypeptides at both the loading domain-module 1
and module 1-module-2 junctions with the docking domain pair from the
phoslactomycin (Plm) PKS.
2. To determine the necessity of either intrapolypeptide linkers or docking
domains for efficient polyketide production by deletion of the natural linker
between module 1 and module 2.
3. To examine the efficiency of loading a synthetic mimic of the natural diketide
intermediate to a series of constructs expressing Pik module 2 in a) its native
context, covalently linked to module 1 which has been catalytically
inactivated, b) when module 2 is expressed as a separate polypeptide from the
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loading domain and module 1 with docking domains in between and c) when
only module 2 is expressed with the N-terminal Plm DD.

Erythromycin (DEBS) PKS
1. To validate the use of Plm docking domains to separate the multimodular
DEBS1-TE polypeptide at the loading domain-module 1 and module 1-module
2 junctions.
2. To examine the effect on triketide lactone production when the docking
domain pair between the PikA3-PikA4 polypeptides (modules 5-6) from the
Pik PKS to dissect the DEBS1-TE multimodular polypeptide.

Borrelidin (BorA5) iterative PKS module
1. To examine the substrate specificity and flexibility of BorA5 to catalyze
multiple elongations in an in vitro setting when the entire module is expressed
as a single protein or when the module is dissected into discrete domains and
expressed as separate polypeptides.
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2. Functional dissection of PikAI from the pikromycin type I polyketide synthase

2.1 Summary
The pikromycin polyketide synthase in Streptomyces venezuelae is comprised
of a loading module and six extension modules, which generate both 12- and 14membered macrolactone products. The first polypeptide of this system, PikAI is a
multimodular component of this PKS and houses both the loading domain and the first
two extension modules. The modules of this protein are joined together by two short
intraprotein amino acid linker sequences. This work has shown that PikAI can be
separated into two proteins at either of these linkers, while retaining the ability to
produce significant quantities of polyketide product. However the ability to produce
methymycin and pikromycin is only retained when matched pairs of docking domains
(DDs) from a heterologous modular phoslactomycin PKS are used in place of the
intraprotein linker. Complete deletion of the linker region without replacement with
DDs resulted in no detectable polyketide production. In both cases, separations at the
LD-module 1 and module 1-module 2 junctions the yields of pikromycin products
produced by the S. venezuelae mutants were 50% of that of an S. venezuelae strain
expressing the native trimodular PikAI. This observation provides the first
demonstration that such separations do not dramatically impact the efficiency of the
entire in vivo biosynthetic process.
Expression of module 2 as a monomodular protein fused to a heterologous Nterminal docking domain was also observed to give almost a 10-fold improvement in
the in vivo generation of pikromycin from a synthetic diketide intermediate. These
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results demonstrate the utility of DDs to manipulate biosynthetic processes catalyzed
by modular PKSs and the quest to generate novel polyketide products. This chapter
has been published as a paper in ChemBioChem 2009, 10(9), 1537-43 (58).

2.2 Introduction
The length and structure of PKS intrapolypeptide linkers and docking domains
(DD) are different (32, 38) but their functional role is equivalent; they mediate transfer
of a growing polyketide chain from the C-terminal ACP of one module to the Nterminal KS of the next module. This functional equivalency raises the question of
whether they can be exchanged for one another without significantly reducing overall
production levels, as well as what are the consequence of deleting the linker sequence
entirely between modules without the substitution of DD.
Replacement of docking domains with an intrapolypeptide linker would permit
an increase in the number of modules on a single polypeptide. An increase from
dimodular to tetramodular polypeptides in the DEBS system has been accomplished
via a different approach of fusing the N- and C-terminal docking domains (59). Other
examples of functional PKS polypeptide fusions have been reported in the aureothin
(60), borrelidin (46), and rapamycin (61) systems. The fusion of two of the three
polypeptides (DEBS1+2 or DEBS 2+3) together yielded comparable production levels
but fusion of all three polypeptides resulted in barely detectable levels when compared
to the wild type system (59). In the aureothin and borrelidin examples functional
fusion of AurA and BorA5 monomodules with their respective adjacent PKS
polypeptides AurB and BorA4 and or BorA6 provided evidence of their iterative
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functionality. In the case of rapamycin, the second module of this PKS was fused
between the first and second module of DEBS, producing a small amount (5%) of the
expected tetraketide product (61). With the exception of the DEBS polypeptide
fusions these examples yielded a significant drop in production levels compared to
control experiments with native modules.
Conversely, replacement of intraprotein linkers with a matched pair of docking
domains from a heterologous system should permit separation of a multimodular
polypeptide into monomodules. Such an experiment has been reported for both the
multimodular components of the rifamycin (62) and epothilone (63) PKS proteins,
when reconstructing these complex pathways in E. coli. For the epothilone case,
EpoD which contains 4 modules was split into two modules using matched DD pair
from the stigmatellin PKS (63). For the rifamycin case the tetramodular RifA was
split into two proteins using a matched DD from the erythromycin PKS (62). In both
cases the yields of the fully extended polyketide products were very low (10 µg/L for
epothilone C). The multimodular separation was also needed to address problems
with expression of soluble multimodular PKS component. Therefore the effect of
multimodular separations on polyketide production in hosts where the multimodular
PKS is expressed as a soluble protein is unknown.
This question has been investigated in the pikromycin producing Streptomyces
venezuelae host, using a heterologous DD pair from the phoslactomycin (Plm) PKS,
(64) to replace the two PikAI intraprotein regions that link the loading domain and
first two extension modules. The results show that such separations lead to only
modest decreases in the overall pikromycin yields.
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2.3 Materials and methods
2.3.1 Commercially purchased materials
All chemicals and antibiotics were purchased from Sigma Aldrich (St. Louis,
MO) unless otherwise noted. Restriction endonucleases and T4 DNA ligase was
purchased from New England Biolabs (Ipswich, MA). PCR primers were custom
synthesized from Integrated DNA Technologies (Coralville, IA). PCR reactions were
carried out with the GC Rich PCR System from Roche (Basel, Switzerland).

2.3.2 Experimental Design
As described above in the introduction, the Pik PKS from S. venezuelae
consists of four separate polypeptides responsible for macrolide biosynthesis. The
first polypeptide (PikAI) is a trimodular protein expressing the loading domain and the
first two extension modules covalently linked together (Figure 5a). The experimental
design employed was built on an established plasmid-based complementation system
in which pDHS722 drives expression of PikAI in BB138 (a PikAI deletion strain of S.
venezuelae). The expression construct pDHS722 is a complementation plasmid that
fully restores pikromycin production to BB138 (65) and was used as a starting point
for the generation of variants pJY12, pJY7 and pJY9 (see results and discussion). In
an analogous manner to which the pDHS722 variants were generated a series of
pBK51 variants (pBK51* and pBK51* scar) was generated for diketide feeding
experiments. Plasmid pBK51 is a complementation plasmid that does not restore
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pikromycin production in BB138 due to the mutation of the active site cysteine residue
in the KS1 domain to alanine.

2.3.3 Plasmids, strains and culture conditions.
All constructed complementation plasmids were derivatives of pDHS722, a
PikA1 complementation plasmid that functions as a conjugative Streptomyces-E. coli
shuttle plasmid. All plasmid DNA manipulations were transformed and purified from
E. coli and the proper plasmid sequences confirmed by restriction digest, PCR
screening and plasmid sequencing before transformation in S. venezuelae.
Transformants were cultivated on LB (Laurie Broth) agar media and plasmids isolated
from LB liquid media, both supplemented with the appropriate antibiotics.
2.3.4 DNA manipulation.
Variants of pDHS722 were prepared by a series of PCR reactions and
subsequent PCR targeting recombination crossovers in E. coli, before final
transformation into S. venezuelae (Figure 11). All DNA sequencing was performed at
Oregon Health and Sciences University, (MMI research core facility) and the data
analyzed with Accelyrs DS Gene Software. DNA encoding the docking domain pair
between modules 1 and 2 of phoslactomycin (Plm) PKS was PCR amplified from
cosmid 10B4 (64) with primers PLMDDF (5'-CTG GGG CAC CTC GAT TTC GG-3')
+ PLMDDR (5'-GTG GTG CTT CGT CTC GGC GT-3'). The PCR program consisted
of an initial hold for 2 minutes at 96°C, followed by 30 cycles of 96 °C, for 30
seconds, 58 °C, for 30 seconds, 72 °C, for 1 minute. This was followed by a final
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extension period at 72 °C for 5 minutes. The PCR product was gel purified with use
of Qiagen Gel Extraction Kit (Valencia, CA) and cloned into TOPO TA 2.1 cloning
vector and subsequently transformed in One Shot Mach1 E. coli cells from Invitrogen
(Carlsbad, CA). The inserts were verified by plasmid sequencing with manufacture
supplied M13F and M13R primers, yielding construct pJY1.

Figure 11. Recombination strategy. General schematic diagram of PCR templates
and PCR products used for recombination in pDHS722 and pBK51. Successful
recombinants were verified by PCR screening and restriction enzyme analysis.
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The apramycin aac (3) IV resistance marker was amplified from pIJ773 (66), using
primers PlmDD-ApraF (5' - CTG ATG CAG TTC ATC GAC ACC GAG TTG GGG
GAC ATC TGA GTA *TAC GGT TCA TGT GCA GCT CCA TC - 3') + PlmDDApra-R (5' - GAA CAG GGC GCG ACG GGA ACA GGA GTG GTG GCA GAG
GAT GTA *TAC TGT AGG CTG GAG CTG CTT C - 3'), (bold, italicized sequences
represent annealing sites for the antibiotic marker and * indicates location of unique
Bstz17I restriction sites introduced for later removal of this marker). The PCR
program consisted of an initial hold at 94 °C, for 2 minutes, followed by 10 cycles of
94 °C for 45 seconds, 55 °C for 30 seconds, 72 °C, for 1 minute. This was followed
by another 15 cycles of 94 °C for 45 seconds, 58 °C for 30 seconds, 72 °C for 90
seconds. This was followed by a final extension period at 72°C for 10 minutes. The
resulting PCR product was recombined with pJY1 via established procedures (66).
The resulting recombinant plasmid pJY2 was isolated from E. coli with a GeneJET
Plasmid Miniprep Kit, Fermentas (Glen Burine, MD) and confirmed by sequencing.
Construct pJY2 was used as a template to generate PCR products with the needed 39nt
sequence complementary to the desired point of recombination between the linked
ACP and KS domains of PikA1. PCR products for the exchange of DNA sequences
encoding the intramodular linkers between modules 1-2 and LD-module 1, for that
coding for the Plm docking domain pair, were amplified with primer pairs PikA1F (5'
- GTC TTC GAC CAC CCG ACG CCG CTG GCC CTC GTG TCG CTG CTG GGG
CAC CTC GAT TTC GG - 3') + PikA1R (5' - GGG GTA GCG GCA GCT CAT CGC
GAC GAT CGC GAT CGG ATC GTG GTG CTT CGT CTC GGC GT - 3') and
LDSepF (5' - TTC GAC TTC CCC ACC CCC GAG GCT CTC GCG GAG CAG
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CTG CTG GGG CAC CTC GAT TTC GG - 3') + LDsepR (5' - GGG CAG GCG GCA
GGC CAT GCC GAC GAT CGC CAC CGG CTC GTG GTG CTT CGT CTC GGC
GT - 3') respectively (primer sequences in bold italicized font represent annealing sites
on the template pJY2 and remaining 5’ region represent the complementary 39nt of
the PikAI region for recombination). The PCR program consisted of an initial hold at
94 °C, for 2 minutes, followed by 15 cycles of 94 °C for 45 seconds, 54 °C for 30
seconds, 72 °C, for 90 seconds. This was followed by another 15 cycles of 94 °C for
45 seconds, 58 °C for 30 seconds, 72 °C for 90 seconds. This was followed by a final
extension period at 72 °C for 10 minutes. PCR products were introduced to pDHS722
by homologous recombination via established protocols (67). Recombinant pDHS722
plasmids, were isolated as described above, treated with restriction enzyme Bstz71I to
remove the apra marker, ligated overnight at 12°C with T4 DNA ligase, transformed
into E. coli and single colonies screened for both (+) Amp and (-) Apra, yielding JY7
and JY12 respectively. The plasmid pJY9, which has had the region encoding the
intrapolypeptide linker between modules 1 and 2 deleted, was also generated by
homologous recombination via established protocols. The apramycin aac (3) IV
resistance marker amplified from pIJ773 was used for deletion of the linker encoding
region with primer Pik link∆F (5’-GTC TTC GAC CAC CCG ACG CCG CTG GCC
CTC GTG TCG CTG TGA GTA* TAC GGT TCA TGT GCA GCT CCA TC –‘3) +
Pik link∆R (5’- GGG GTA GCG GCA GCT CAT CGC GAC GAT CGC GAT CGG
ATC CAC CTA TCG GCT TCG CGG CTG TCC GCC CGG TA*T ACT GTA GGC
TGG AGC TGC TTC - ‘3). Bold and italicized regions represent annealing regions
for the resistance marker and * indicates location of the unique Bstz17I restriction sites
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introduced for later removal of this marker. A TGA stop codon (underlined and bold
text) was introduced at the 3’ end of the module 1 ACP encoding region in the forward
primer. The reverse primer contained the complementary sequence to the associated
RBS (underlined) and start codon (CAC) of the N-terminal Plm DD (underlined and
bold text) fused to the beginning of the KS module 2 encoding region. The PCR
program consisted of an initial hold at 94 °C, for 2 minutes, followed by 15 cycles of
94 °C for 45 seconds, 54 °C for 30 seconds, 72 °C, for 90 seconds. This was followed
by another 15 cycles of 94 °C for 45 seconds, 58 °C for 30 seconds, 72 °C for 90
seconds. This was followed by a final extension period at 72 °C for 10 minutes. This
PCR product was again recombined into pDHS722 via established protocols and the
apramycin aac (3)IV resistance marker was removed by restriction enzyme digestion
with Bstz17I as before and re-ligated to yield the final pJY9 plasmid.
PBK51* was generated in the same manner as pJY7 but using pBK51
(encoding PikAI with a Cys to Ala mutation on KS1) as the final recombination
plasmid. The plasmid pJY7*, which expresses only the C terminal PLM DD fused to
module 2 of PikAI was generated from pJY7 by the PCR-targeted Streptomyces gene
replacement method (66). For this the DNA encoding the polypeptide containing just
the loading domain, module 1 and the N-terminal PLM DD in pJY7 was replaced with
the kanamycin resistance marker. This marker was amplified from pKD13 (67) with
primers PikA1scarF (5' - GTT GGG TGA AAG CGC GGC TTC CGG AGA CGG
AGC CGG ATG ATT CCG GGG ATC CGT CGA CC - 3') + PikAlscarR (5' - GCG
ACG GGA ACA GGG GTG GTG GCA GAG GAT GTA TAC TCA TGT AGG CTG
GAG CTG CTT C - 3') (bold sequences represent annealing sites for the antibiotic
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marker with remaining 5’ regions representing recombination crossover sites). The
PCR program consisted of an initial hold at 94 °C, for 2 minutes, followed by 10
cycles of 94 °C for 45 seconds, 50 °C for 45 seconds, 72 °C, for 90 seconds. This was
followed by another 15 cycles of 94 °C for 45 seconds, 55 °C for 45 seconds, 72 °C
for 90 seconds. This was followed by a final extension period at 72 °C for 10 minutes.
Successful replacement in pJY7 was followed by FLP mediated excision of the marker
region generating pJY7*, which encodes for the expression of PikAI module 2 with
the C-terminal docking domain of Plm2-3 at the N terminus.

2.3.5 Transformation of S. venezuelae
Generated plasmid complementation variants of pDHS722 were individually
transformed into the PikA1 deletion strain (BB138) of S. venezuelae by established
protocols (68) with slight modifications. BB138 protoplasts were prepared by
standard methods. Frozen protoplasts were thawed quickly by hand warming,
followed by centrifugation at 3000 rpm for 5 minutes in an Eppendorf Minispin Micro
Centrifuge. Following centrifugation the supernatant was gently removed by pipet,
leaving approximately 100 µL total volume. To the cells 10 µL (500-600 µg) of the
respective plasmid DNA was added, followed immediately by 600 µL of a sterilized
25% 8000 PEG solution in P buffer. P (basic) buffer consisted of 103g sucrose, 0.25g
K2SO4, 2.02g MgCl2•6H2O, and 2mL of trace element solution in 800mL H2O. Trace
element solution was prepared by dissolving 40mg ZnCl2, 200mg FeCl3•6H2O, 10mg
CuCl2•2H2O, 10mg MnCl2•4H2O, 10mg NaB4O7•10H2O, 10mg (NH4)6Mo7O24•4H2O
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in 1L of H2O. Both solutions were sterilized separately. After sterilization to 80mL of
P basic buffer was added 1mL 0.5%KH2PO4, 10mL 3.68% CaCl2•2H2O, and 10mL
5.73% TES (pH 7.2) to give the final P buffer solution.
The cell mixture solution was gently pipeted up and down three times and
plated onto R2YE agar (10.3% sucrose, 0.025 K2SO4, 1.1% MgCl2, 1% glucose 0.01%
Difco Casaminoacids, 0.005% yeast extract, 1% trace element solution, 2.2% agar)
plates. Plates were allowed to incubate at room temperature overnight and
subsequently overlaid with 500µg of thiostrepton in 1mL of LB media. Plates were
incubated at 30°C for 4-5 days until single colonies were observed. These colonies
were subsequently grown on SPA agar (0.1% yeast extract, 0.1% beef extract, 0.2 %
tryptone, 1% glucose, 1.5% agar) plates (50mg mg/L thiostrepton) for 3 days. Spores
from these plates were scrapped for SCM liquid (1.5% soluble starch, 2% soytone,
0.01% CaCl2, 0.15% yeast extract, 1.05% MOPS, pH 7.2) media fermentations and
propagation of S. venezuelae strains carrying the desired complementation plasmids
(68).

2.3.6 Synthesis of diketide NAC thioester of 2(S)-methyl-3(R)-hydroxypentanoic
acid
Synthesis of the NAC thioester of 2(S)-methyl-3(R)-hydroxypentanoic acid
was completed as detailed in scheme 1 following previously published methods (69,
70). All reactions were carried out under nitrogen using dry solvents under anhydrous
conditions, unless otherwise noted. Normal phase flash column chromatography was
carried out using Davisil® silica gel (100-200 mesh). Preparative thin-layer
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chromatography (PTLC) separations were carried out on 1 mm, or 2 mm E. Merck
silica gel plates (60F-254). 1H NMR spectra were recorded on Tecmag Libramodified NM-500 MHz or Bruker AC-F 300 MHz spectrometers and calibrated using
residual undeuterated solvent as an internal reference. High-resolution mass spectra
(HRMS) were recorded on a Micromass LCT Electrospray mass spectrometer
performed at the Mass Spectrometry & Proteomics Facility (The Ohio State
University).

Scheme 1. Synthesis of NAC diketide thioester. Reagents and conditions: a) DBBT,
DIEA, CH2Cl2, CH3CHO; b) TBSOTf, 2,6-Lutadiene CH2Cl2; c) LiOH, THF/H2O
(3:1); d) ACHN(CH2)2SH, EDCI, DMAP, CH2Cl2; e) 48% HF, CH3CN, H2O.
Generation of compound 2 (Aldol)
To a stirred solution of Evans’ acyl-oxazolidinone 1 (0.32g, 1.29 mmol) in
CH2Cl2 (3 ml, 0.3 M) at 0oC were added diisopropylethylamine (1.30 ml, 1.29 mmol)
and dibutylboron triflate (1.0 M in CH2Cl2, 1.30 ml, 1.29 mmol). The resulting
reaction mixture was stirred at 0oC for 30 min and then cooled to -78oC.
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Propionaldehyde (0.05 g, 0.86 mmol) in CH2Cl2 was added and the mixture was
stirred at -78 oC for 1 h and then allowed to warm to 0oC. After stirring for 2 hrs at
0oC the reaction was quenched by the addition of phosphate buffer pH 7 (1 ml). The
reaction mixture was poured into a flask containing MeOH (4.3 ml) at 0oC and treated
with precooled 30% H2O2 (5.4 ml) and stirred at 0oC for 1 hr. MeOH was removed by
rotary evaporation, saturated aqueous NaHCO3 was added and the resultant aqueous
layer was extracted with CH2Cl2 (3 x 5 ml) and purified by flash silica gel
chromatography (silica gel, 10% EtOAc/hexanes) to afford the aldol, 2: 1H NMR (500
MHz, CDCl3) δ 7.37-7.20 (m, 5H), 4.74-4.70 (m, 1H), 4.26-4.19 (m, 2H), 3.90-3.86
(m, 1H), 3.82-3.78 (m, 1H), 3.27 (dd, J = 3.5, 13.5 Hz, 1H), 2.88 (m, 1H), 2.80 (dd, J
= 10, 13.5 Hz, 1H), 1.65-1.45 (m, 2H), 1.26 (d, J = 7.5 Hz, 3H), 0.99 (t, J = 7.5 Hz,
3H).

Generation of compound 3 (Protected Aldol)
To a solution of 2 (1.45 g, 4.97 mmol) in CH2Cl2 at 0oC was added 2,6-lutidine
(1.73 ml, 14.9 mmol). After stirring for 5 min at that temperature, tertbutyldimethylsilyltrifluoromethane sulfonate (1.71 ml, 7.5 mmol) was added drop
wise and the reaction mixture was stirred at 0°C for 20 min after which time no
starting material was detected by TLC. Saturated aqueous NH4Cl was added. The
organic phase was separated, and the aqueous layer was extracted with CH2Cl2 (3 x 30
ml). The combined organic extracts were dried over anhydrous Na2SO4, concentrated
and purified by flash silica gel chromatography (silica gel, 1% EtOAc/hexanes) to
afford 3: 1H NMR (500 MHz, CDCl3) δ 7.36-7.22 (m, 5H), 4.63-4.59 (m, 1H), 4.1943

4.15 (m, 2H), 3.97 (q, J = 5.0 Hz, 1H), 3.91-3.87 (m, 1H), 3.31 (dd, J = 3.0, 13.5 Hz,
1H), 2.77 (dd, J = 10.0, 13.5 Hz, 1H), 1.58-1.55 (m, 2H), 1.21 (d, J = 7.0 Hz, 3H),
0.92-0.88 (m, 12H), 0.03 (d, J = 9.5 Hz, 6H).

Generation of compound 4 (hydrolysis of chiral auxiliary)
To a suspension of 3 (0.05 g, 0.123 mmol) in a mixture of THF (0.96 ml) and
water (0.33 ml) at 0oC was added LiOH•H2O (0.10 g, 0.246 mmol) and 30 % H2O2
(0.06 ml, 0.49 mmol). The reaction mixture was allowed to stir at 0oC for 1 hr after
which it was quenched by addition of sodium sulfite solution (1.5 M). The mixture
was concentrated and aqueous phase was washed with dichloromethane and then
carefully acidified to pH ~2 with 1N aqueous HCl. The mixture was extracted with
diethyl ether and the combined organic extracts were dried over anhydrous sodium
sulfate and concentrated in vacuo. The crude product was subjected to flash column
chromatography (silica gel, 10% EtOAc/hexanes) to give 4: 1H NMR (500 MHz,
CDCl3) δ 3.93 (q, J = 5.5 Hz, 1H), 2.65-2.60 (m, 1H), 1.60-1.47 (m, 2H), 1.14 (d, J =
7.5 Hz, 3H), 0.93-0.90 (m, 12H), 0.09 (d, J = 9.5 Hz, 6H).

Generation of compound 5 (NAC thioester of 4)
A solution of carboxylic acid 4 (0.37 g, 1.49 mmol) in anhydrous methylene
chloride (7.5 ml) was cooled to 0 oC for 15 min. N-acetyl cysteamine (47 mg, 0.394
mmol) was added to this solution, followed by 4-(N,N-dimethylamino) pyridine (0.21
g, 1.8 mmol), and N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride
(0.04 g, 0.30 mmol). The mixture was allowed to warm to room temperature and
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stirred overnight. Saturated aqueous NH4Cl solution (7 ml) was added and the organic
phase was separated. The aqueous phase was extracted with 3 x 15 ml of ether and the
combined organic phases were dried over anhydrous sodium sulfate and concentrated
in vacuo. The residue was purified by column chromatography (silica gel, 30%
EtOAc/hexanes) to afford 5: 1H NMR (500 MHz, CDCl3) 5.85 (br, 1H), 3.91 (q, J =
6.0 Hz, 1H), 3.48-3.40 (m, 2H), 3.01 (t, J = 6.0 Hz, 2H), 2.82-2.77 (m, 1H), 1.97 (s,
3H), 1.66 (s, 1H), 1.57-1.46 (m, 2H), 1.17 (d, J = 6.5 Hz, 3H), 0.91-0.87 (m, 12H),
0.04 (d, J = 9.0 Hz, 6H).

Generation of compound 6 (deprotection of 5)
To a solution of the protected NAC thioester (0.24 g, 0.68 mmol) in
acetonitrile (6 ml, 0.1 M) and water (1.3 ml, 0.6M) was added hydrofluoric acid (1.6
ml, 48% wt in H2O). After stirring for 2 hrs at room temperature the reaction was cool
to 0oC and pH was adjusted to 7.5 using saturated aqueous NaHCO3. Acetonitrile was
removed by rotary evaporation and the resultant aqueous layer was extracted with
EtOAc (3 x 10 ml). The combined organic extracts dried over anhydrous Na2SO4,
concentrated and purified by flash silica gel chromatography (silica gel, 10%
MeOH/CH2Cl2) to afford the final diketide NAC thioester 6: 1H NMR (500 MHz,
CDCl3) δ 6.02 (br, 1H), 3.85-3.32 (m, 1H), 3.48-3.40 (m, 2H), 3.07-2.98 (m, 2H),
2.76-2.71 (m, 1H), 2.61 (s, 1H), 1.96 (s, 3H), 1.56-1.41 (m, 2H), 1.20 (d, J = 7.0 Hz,
3H), 0.96 (J = 8.0 Hz, 3H). HRMS calculated for C10H19NO3S + Na 256.098; found
256.097.
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2.3.7 Polyketide production analysis
Polyketide production was analyzed from 10 mL SCM media supplemented
with thiostrepton (50 mg/L) fermentations carried out at 30°C with agitation (220 rpm)
for 72 hours. After fermentation the medium was separated by centrifugation at
10,000 rpm for 10 min. The fermentation media was extracted 3X with 10 mL of
EtoAC, dried by rotary evaporation, and re-suspended in 1mL of MeOH. Extracts of
BB138/(pJY7, pJY12, pJY9, pBK51, pBK51* and pJY7*) were analyzed for
pikromycin production by reverse phase HPLC on an Agilent 1100 series system with
a 5µm Discovery HS C18 reverse phase column (25 x 4.6 cm, Supelco), with a linear
gradient system from solvent A (20:80 acetonitrile: water -10mM ammonium acetate)
to solvent B (80:20 acetonitrile: water -10mM ammonium acetate) over 50 min at a
flow rate of 1 mL/min with UV detection at 220nm. Relative amounts were
determined by integrating and averaging the peak areas for pikromycin produced in 3
separate extracts and compared to extracts of BB138/pDHS722. Extracts were also
analyzed by LC-MS to correlate the observed retention times with the appropriate
masses for both methymycin and pikromycin. LC-MS analysis was carried out using
20 µL of each extract under the same solvent system conditions at a rate of 0.3
mL/min with a Surveyor HPLC system (ThermoFinnigan) connected to a diode array
detector equipped with a 2.1 µm Discovery HS C18 reverse phase column (25 x 4.6
cm Supleco). Mass spectra were collected on an LCQ quadrupole ion trap
(ThermoFinnigan) mass spectrometer equipped with an electrospray ion source in
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positive mode (Oregon Health and Sciences University, Mass Spectrometry core
facility).
Diketide feeding experiments to strain BB138 carrying plasmids pBK51,
pBK51* or pJY7* were completed by initially starting with an overnight seed culture.
100 µL of this culture (1%) was added to fresh 10 mL SCM fermentations with
addition of 50mg mg/L thiostrepton. After agitation for 10 hours at the above
conditions, the diketide was added from a stock solution in MeOH to a final
concentration of 1mM, (MeOH alone was used a negative control), and the
fermentation process permitted to continue for approximately additional 60 hours.
Analyses of polyketide production were carried out as described above.

2.3.8 Plasmid confirmation
In order to determine that no cross contamination had occurred and that each
transformation of BB138 carried the intended plasmid only, plasmid DNA was
isolated from S. venezuelae and confirmed by PCR screening with primers specifically
designed for plasmid sequencing (Figure 12). PCR amplification of the region
encoding the natural intrapolypeptide linker yields a product that is approximately 400
base pairs while the recombinant pDHS722 variants are approximately 400 base pairs
larger, at approximately 800 base pairs.
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Figure 12. PCR confirmation of plasmids isolated from S. venezuelae. Plasmids
pDHS722 and pJY7 were isolated from strain BB138 and used as templates for PCR
confirmation along side authentic pDHS722 and pJY7 standards. PCR amplification
was completed with specifically generated sequencing primers previously used for
plasmid sequencing. Lanes 1 and 2 are PCR products from authentic pDHS722 and
pJY7 respectively. Lanes 3 and 4 are PCR products from BB138 purified plasmids
pDHS722 and pJY7 respectively. The PCR product of pJY7 is approximately 800
base pairs compared to pDHS722, which is approximately 400 base pairs.
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2.4 Results and Discussion
2.4.1 Consequences of substituting linkers for DD in PikAI
Triplicate liquid fermentations of each S. venezuelae BB138 carrying
pDHS722, pJY12, pJY7 or pJY9 respectively were carried out in order to determine if
these three complementation variants produced the expected antibiotic products.
Detection and quantification of methymycin and pikromycin products was performed
using HPLC analysis combined with UV and MS (m/z = 470 and 526 in positive
mode), and confirmed with authentic standards (Figure 13a-c). Production of
methymycin and pikromycin were observed in both BB138/pJY12 and BB138/pJY7,
and was approximately 50% of that observed for BB138/pDHS722 (Figure 13).
However, in the case of BB138/pJY9 where no linker or DD pair is present between
modules 1 and 2 only trace amounts of the polyketide products were detected, <0.1%
compared to intact PikA1 (pDHS722) (Figure 14). This dramatic decrease in
pikromycin yields likely indicates that in the separated modules without DDs, protein
recognition between the ACP of module 1 and the KS of module 2 is not sufficient to
permit transfer from module 1 to 2. Alternatively, the expression of a soluble separate
module 2 may be lower without either the natural linker or in the case of pJY7 an Nterminal DD being present. Indeed, reported work by Khosla et al. on in vitro
expression of individual PKS monomodule (33, 71-73) and specifically Pik module 2
(74) has shown that an N-terminal stretch of amino acids (linker or DD) is required for
the expression and catalytic activity of these proteins. The trace levels of pikromycin
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detected in BB138/pJY9 fermentations demonstrate some level of expression of this
protein.

pDHS722

Figure 13. HPLC and LC-MS analysis of methymycin and pikromycin
production. a) Overlaid HPLC trace for fermentations of BB138 carrying the
indicated complementation plasmids. b) Selected ion monitoring for the expected
macrolide products methymycin and pikromycin eluting at approximately 15 and 21
min respectively. c) Mass spectra of the products methymycin and pikromycin (m/z =
470 and 526) in positive mode respectively.
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Figure 14. Levels of pikromycin products made in the BB138 PikAI deletion
strain of S. venezuelae with respective complementation plasmids. Red block
shapes indicate the Plm1- Plm2-3 docking domain pair from the phoslactomycin
system. Diketide feeding experiments were carried out only with BB138 carrying
constructs expressing PikAI in which module 1 was either inactive (through
mutational inactivation of the KS domain, indicated by an X), absent (pJY7*) or
missing the C-terminal DD (pJY9): N/A (not applicable) and N/D (not detectable).
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2.4.2 Directed biosynthesis, feeding NAC thioester to module 2
Fermentations of BB138 carrying pBK51, pBK51* or pJY7* did not produce
any detectable levels of methymycin or pikromycin, consistent with either loss of the
loading domain and module 1 of PikAI, or mutational inactivation of module 1. These
fermentations were also performed in the presence of the NAC thioester of 2(S)methyl-3(R)-hydroxypentanoic acid, the natural diketide intermediate with production
monitored by LC-MS (Figure 15a-d).

Figure 15a. Two routes to prime the pikromycin PKS and provide 12 and 14membered macrocyclic products. The natural process occurs with generation of
enzyme-bound propionate starter unit of the loading domain from methylmalonyl
CoA. An alternate, less efficient route which can occur in the absence of the loading
domain and module 1 or mutational inactivation of module 1 is transfer of the diketide
intermediate, 2(S)-methyl-3(R)-hydroxypentanoic acid (activated as a NAC thioester)
onto the KS domain of module 2.
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Figure 15b. LC-MS analysis of BB138/pBK51 grown in the presences of NAC
thioester of 2(S)-methyl-3(R)-pentanoic acid.
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Figure 15c. LC-MS analysis of BB138/pBK51* grown in the presence of NAC
thioester of 2(S)-methyl-3(R)-pentanoic acid.
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Figure 15d. LC-MS analysis of BB138/pYJ7* grown in the presences of NAC
thioester of 2(S)-methyl-3(R)-pentanoic acid.
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Fermentations were conducted three times; product yields and standard deviation were
calculated relative to those obtained with BB138/pDHS722 (Figure 14). Levels of
pikromycin production in the cases of BB138/pBK51 (Figure 15b) were extremely
low, much less than 1% of that observed in the control culture. This result contrasts
with previous experiments, which have demonstrated that for the DEBS PKS, the
natural diketide intermediate is able to load onto the second module of a dimodular
polypeptide in an efficient manner (75). This observation with DEBS has been
reported in a number of hosts and in this laboratory BB138/pBK3 has been used, (76)
which produces the truncated DEBS PKS triketide lactone product to show that it also
functions similarly in S. venezuelae. It has also been shown that feeding the natural
triketide intermediate to either BB138 or BB138/pBK51 gives pikromycin yields of
10% of that observed for control (77). The low levels of pikromycin production were
increased to about 2% of the control with BB138/pBK51* (Figure 15c), indicating a
modest improvement in diketide utilization may result from expressing module 2 as a
monomodular polypeptide. Notably, a significant increase was seen with
BB138/pJY7* in which the pikromycin yields were about 8% (Figure 15d) of the
control and comparable to that observed with feeding the triketide intermediates. Thus
removal of the preceding module rather than separation of the two modules is more
effective at improving utilization of the diketide intermediate (improvements in
utilization of diketides for erythromycin biosynthesis have also been observed upon
removal of module 1 of DEBS) (53). This result may indicate that even as separate
polypeptide the loading domain and module 1 may negatively impact loading of
diketide onto module 2. Alternatively, the process may simply be inefficient
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regardless of the presence of the preceding module and the improvements may reflect
better expression of the new monomodular module 2. The efficient utilization of the
natural diketide by a separated module 2 was only observed when there was an Nterminal docking domain. There was no improvement in the trace levels of
pikromycin made by BB138/pJY9 when grown in the presence the diketide
intermediate (suggesting that that the separate module 2 without an N-terminal DD is
either catalytically impaired or poorly expressed).

2.5 Conclusion
These experiments have provided an additional in vivo example that a
multimodular PKS can be separated into individual modules by replacing the
intrapolypeptide linker with a heterologous DD pair. Moreover, these observations
demonstrate for the first time that the multimodular separation of these complex
multifunctional proteins can lead to only a modest decrease in the overall production
of the final polyketide product compared to the intact protein. Additionally, this work
has demonstrated that simply separating multimodular PKS proteins without DDs
results in a tremendous drop in polyketide production. Such dissected systems that
utilize DD interactions, make multimodular PKSs more amenable for the creation of
hybrid PKSs and potentially the creation of new polyketide products. However, there
are still many challenges associated with a) the appropriate molecular recognition
between the ACP and KS domains, and b) the substrate specificity of the catalytic
domains. An alternative approach to generating novel polyketide products is feeding
NAC thioesters of analogs of polyketide intermediates. This approach also faces the
57

challenge associated with substrate specificity of the catalytic domains, and
inefficiencies of loading onto the KS of the appropriate module. In the case of PikAI
it has been shown that the in vivo utilization of the natural NAC- diketide intermediate
by a multimodular protein is very inefficient, but can be improved significantly by
removal of the preceding modules and expression of the appropriate loading module
with an N-terminal docking domain.
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3. Functional modular dissection of the trimodular DEBS1-TE results in an
unexpected shift in triketide lactone ratios and provides new insights into aspects
of acyl group loading and hydrolysis

3.1 Summary
The ability of DEBS 1, the first of the three polypeptides from the 6deoxyerythronolide B (DEBS) polyketide synthase of Saccharolyspora erythraea to
produce triketide lactone products when the DEBS thioesterase domain is covalently
fused to the C-terminal of the protein has been reported in both in vivo and in vitro
experiments. Plasmid-based expression of the intact DEBS1-TE fusion protein in a
variety of streptomyces hosts, including S. venezuelae results in efficient triketide
lactone production, where the observed preference is for a product derived from a
propionate starter unit. In addition to the propionate-derived compound, acetate,
butyrate, and isobutyrate derived compounds have also been observed. Previous
results showed that PikAI from the pikromycin/methymycin PKS can be separated at
the loading domain-module 1 and module 1-module 2 junctions with a matched pair of
docking domains from the phoslactomycin PKS. This separation method was applied
to the DEBS1-TE PKS polypeptide to examine if another PKS multimodular protein
could be efficiently separated with docking domains. The phoslactomycin docking
domain pair was again utilized for this separation of DEBS1-TE as well as another
docking domain pair, PikA3-PikA4 from the pikromycin PKS.
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This work has shown that dissection of DEBS1-TE at the two module-module
junctions also results in only a modest decrease in the overall yields of polyketide
products (triketide lactones) when compared to intact DEBS1-TE. However an
unexpected shift in triketide lactone ratios favoring the isobutyrate derived product
was observed. These observations along with radiolabeling and acyl CoA hydrolysis
experiments with the stand alone DEBS loading domain (ATL-ACPL) have led to new
insights into a) the rate of AT acylation and the subsequent hydrolysis of the acyl
group off of the AT domain and b) relative rates for the subsequent transfer step of an
AT bound acyl group to the holo ACP domain has been investigated.

3.2 Introduction
Much of the information to date regarding structure, function, and domain
organization of type I modular polyketide synthases has been derived from genetic and
biochemical studies involving the 6-deoxyerythronolide B (DEBS) PKS from
Saccharopolyspora erythraea, as described in chapter 1. This PKS produces the
macrocyclic lactone core of the antibiotic erythromycin. The genes encoding the PKS
enzymes responsible for the biosynthesis of DEBS were the first type I PKS cluster to
be sequenced in its entirety and as a result has been one of the most well studied PKS
systems (78, 11-13). The information, which the DEBS PKS has revealed in regards
to functional domains and module organization, has laid the foundation for virtually
all analyses of modular PKSs (79). One of the key factors which has made the DEBS
PKS such a well studied system is the ability for either all or part of the DEBS
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biosynthetic gene cluster to be successfully expressed in several heterologous hosts
other than Saccharopolyspora erythraea, including S. venezuelae (75, 80-83).
One of the unique features of the DEBS PKS is the ability of the loading
domain AT to utilize a variety of different starter units. Despite the strict substrate
specificity that extension module AT domains typically display (79, 55) PKS loading
domain ATs from the DEBS and avermectin systems have relaxed substrate specificity
capable of incorporating a variety of starter units (80, 84-86). Although the natural
starter unit for erythromycin biosynthesis is propionate, the DEBS ATL-ACPL and
specifically the AT domain been shown to have a certain amount of flexibility. Other
starter units such as acetyl, butyrl, isobutyryl, cylopropionate, and cyclobutyryl have
been shown to be processed by DEBS into their final corresponding products, albeit
with much lower production levels (55, 56, 80, 84, 85, 87). The observation of novel
erythromycin analogs not only means that the ATL has relaxed substrate specificity but
also that the catalytic domains in downstream modules to some extent do as well.
This relaxed processing capacity has made DEBS one of the most genetically
engineered and manipulated PKSs. Despite the seemingly broad substrate flexibility,
which DEBS exhibits, not all down-stream PKS modules have the ability to process a
variety of different substrates. The inefficiency of alternate substrate processing and
the presumed blockage of PKS protein active sites is one of the major hurdles for
genetic engineering, combinatorial, and precursor-directed biosynthetic efforts.
One possible mechanism to remove acyl intermediates, which can not be
properly processed has been attributed to the activity of specific thioesterases, which
have been proposed to act as housekeeping or editing enzymes (88-90). Genes
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encoding an additional thioesterase enzyme to the one generally required for the
release of the final polyketide product have been reported in the PKS biosynthetic
clusters of many of many polyketide pathways; such as erythromycin from
Saccharopolyspora erythraea (91), rifamycin from Amycolatopsis mediterranei (92),
tylosin from Streptomyces fradiae (93), and pikromycin/methymycin from
Streptomyces venezuelae (51). These enzymes hydrolyze acyl groups of mis-acylated
ACP domains by cleavage of the acyl group from the 4’-phosphopantetheine
prosthetic arm of the ACP domain (94, 95) (Figure 16a). Improperly acylated ACP
domains can arise from the premature decarboxylation of the selected extender unit,
resulting in an acyl-ACP which blocks polyketide biosynthesis and must be removed
for the biosynthetic process to proceed. In vitro evidence from the tylosin (96) and
Pik (94) PKS systems has shown that the TEII enzyme for each respective system, can
process the removal of acyl groups bound to ACP domains. However these enzymes
possess higher affinities for acyl groups, which lack the carboxyl group needed for
polyketide decarboxylative chain elongation.
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Figure 16. Proposed mechanisms for the removal of acyl groups from DEBS
ATL-ACPL. Proposed mechanisms for removal of loaded acyl groups a) TE cleavage
of ACP bound acyl intermediate b) water induced hydrolysis of AT bound acyl
intermediate. c) Proposed dynamic equilibrium of an acyl group between the AT and
ACP domains of a PKS.
Published work has shown that when the DEBS TE domain is covalently fused
to the C-terminal of DEBS1, this fusion protein is capable of loading a starter unit and
catalyzing two rounds of elongation before the terminal TE domain catalyzes the
formation of the predicted triketide lactone (TKL) product (54, 80, 84, 97) (Figure
10b). Based on the similarities in the modular organization of DEBS1 and PikAI from
the Pik PKS as well as an established method to screen for triketide lactone
production, it was sought to expand on the successful results from the experiments
described in chapter 2, separating multimodular PKS proteins with matched docking
domains. The goals of this work were to determine whether or not replacing the
natural intrapolypeptide linkers in DEBS1 between the loading domain and module 1
and module 1 and module 2 with the Plm1-Plm2 DD pair would again result in an
efficient dissected PKS system. This work was accomplished by generating variants
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of expression construct pBK1 (76), which expresses DEBS1-TE and produces acetate,
propionate, and isobutyrate derived triketide lactone, when expressed in S. venezuelae.
In addition to the Plm DD pair, the impact on production when another set of docking
domains, PikA3-A4 DD from the pikromycin PKS was examined by insertion of this
pair between the first and second extension module of DEBS1. This particular set of
DDs, for which a crystal structure (Figure 17) (PDB ID 3F5H) was recently published,
it was selected based on intriguing binding data showing that this pair exhibited the
highest binding affinity for one another when compared to the other DEBS and Pik
docking domain pairs (40).

Figure 17. PikA3-A4 PKS docking interface structures. a) Highlighted PikA3
ACPdd/PikA4 KSdd pair (PDB id 3F5H). b) Three PikA3/PikA4 docking dimers are
shown. The docking interaction formed by neighboring dimers is highlighted.
(Reproduced with permission from (48) License Number: 2427290325871)
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By using the Plm docking domain pair previously used in the Pik system
(chapter 2) to dissect the trimodular DEBS1-TE polypeptide, a dramatic change in the
ratio of triketide lactone products was observed. Investigations into this phenomenon
have revealed a second mechanism for the removal of acyl groups from the loading didomain, which occurs via hydrolysis of acyl groups bound to the AT domain (Figure
16b). In this proposed mechanism an acyl group bound to the active site serine of an
AT domain can be hydrolyzed yielding the carboxylic acid of the bound acyl group
and the unmodified serine residue of the AT domain. The data from this work
demonstrates that different acyl groups such as propionate and isobutyrate transfer
from the AT to the ACP at different rates and that the AT to ACP transfer is
reversible.
For a loading domain ATL-ACPL, the position of the equilibrium between
either the AT or ACP bound form (Figure 16c) depends on two factors that are
important for the normal polyketide biosynthetic process; one is the rate of transfer for
acyl groups bound to the AT domain to the holo ACP domain and the second is the
rate of transfer to the subsequent KS domain of the first extension module. This
equilibrium between the AT and ACP domains determines the levels of acyl groups
which are either cleaved from the ACP domain by thioesterases or hydrolyzed from
the AT domain.
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3.3 Materials and Methods
3.3.1 Commercially purchased materials
All chemicals and antibiotics were purchased from Sigma Aldrich (St. Louis,
MO) unless otherwise noted. Restriction endonucleases and T4 DNA ligase were
purchased from New England Biolabs (Ipswich, MA). PCR primers were custom
synthesized from Integrated DNA Technologies (Coralville, IA). PCR reactions were
carried out with the GC Rich PCR System from Roche (Basel, Switzerland).

3.3.2 Plasmids, strains and culture conditions
All constructed plasmids were derivatives of pBK1, a DEBS1+TE expression
plasmid (76). Construct pBK1 was derived from pSE34, a multicopy shuttle plasmid
containing the ermE* promoter, provided by Pfizer (Groton, CT). All plasmid
manipulations were completed in E. coli hosts. Transformants were cultivated on
LB/agar media and plasmids isolated from LB liquid media, both supplemented with
appropriate antibiotics. Generated variants of the pBK1 were transformed into BB138
or AX912 by established protocols (68) onto R2YE plates. Transformants were
subsequently grown on SPA agar plates (50mg mg/L thiostrepton). SCM liquid media
was used for fermentation and propagation of S. venezuelae strains.

3.3.3 DNA manipulation
Variants of pBK1 were prepared by a series of PCR reactions and subsequent
PCR targeted recombination crossovers in E. coli, before final transformation into
Streptomyces venezuelae. Previously reported construct pJY2 (58) was used as a
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template for the amplification of PCR products containing the encoding region for the
apramycin resistance marker and the Plm DD pair along with the needed 39 nt
complementary to the desired point of recombination between the linked ACP and KS
domains of DEBS1. PCR products for the exchange of DNA sequences encoding the
intramodular linkers between the LD-module 1 and modules 1-2 of DEBS1 for that
coding for the Plm docking domain pair, were amplified with primer pairs DEBS LD
sep F (5' – CAC CCG ACT CCG CGT GCG CTC GCG GAA GCA CTC GCG GCG
CTG GGG CAC CTC GAT TTC GG - 3') + DEBS LD sep R (5' – GGG CAG CCG
GCA GGC CAT CGC GAC GAC CGC GAC CGG TTC GTG GTG CTT CGT CTC
GGC GT - 3') and DEBS M1-M2 sep F (5' – GAC GTG CGG ACG CTG GCG GCG
CAC CTG GCC GCC GAA CTC CTG GGG CAC CTC GAT TTC GG - 3') + DEBS
M1-M2 sep R (5' – GGGC AGC CGG CAC GCC ATG CCG ACG ATC GCG ATC
GGC TCG GTG GTG CTT CGT CTC GGC GT - 3') respectively. The primer
sequences in bold/italic represent annealing sites on the template pJY2 and remaining
5’ region the needed complementary 39nt of the DEBS1 region for recombination.
The PCR program consisted of an initial hold at 94 °C, for 2 minutes, followed by 15
cycles of 94 °C for 45 seconds, 54 °C for 30 seconds, 72 °C, for 90 seconds. This was
followed by another 15 cycles of 94 °C for 45 seconds, 58 °C for 30 seconds, 72 °C
for 90 seconds. This was followed by a final extension period at 72 °C for 10 minutes.
PCR products were introduced to pBK1 by homologous recombination via established
protocols (66). Recombinant pBK1 plasmids were isolated as before, treated with
Bstz71I to remove the apramycin marker, ligated overnight at 12°C, transformed into
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E. coli. Single colonies were screened for both (+) Amp and (-) Apra, yielding pBK1*
and pBK1** respectively.
Plasmid pBK1* scar, which expresses only modules 1 and 2 of DEBS1 was
generated from pBK1* by the PCR-targeted Streptomyces gene replacement method
(66). For this the DNA encoding the polypeptide containing the loading domain and
the N-terminal PLM DD in pBK1* was replaced with the kanamycin resistance
marker. This marker was amplified from pKD13 (66) with primers DEBS LD scar F
(5' – GGG CAG CCG GCA CGC CAT GCC GAC GAT CGC GAT CGG CTC G
ATT CCG GGG ATC CGT CGA CC - 3') + DEBS LD scar R (5' - GCG ACG GGA
ACA GGG GTG GTG GCA GAG GAT GTA TAC TCA TGT AGG CTG GAG CTG
CTT C - 3') (bold/italic sequences represent annealing sites for the antibiotic marker
with remaining 5’ regions representing recombination crossover sites). The PCR
program consisted of an initial hold at 94 °C, for 2 minutes, followed by 10 cycles of
94 °C for 45 seconds, 50 °C for 45 seconds, 72 °C for 90 seconds. This was followed
by another 15 cycles of 94 °C for 45 seconds, 55 °C for 45 seconds, 72 °C for 90
seconds. This was followed by a final extension period at 72 °C for 10 minutes.
Successful replacement in pBK1* was followed by FLP mediated excision of the
marker region generating pBK1* scar, which encodes for the expression of DEBS1
module 1 with the C-terminal docking domain of Plm2-3 at the N-terminus.
Expression construct pJY105 which expresses DEBS1-TE with the PikA3-A4
DD pair in place of the intrapolypeptide linker between module 1 and module 2 was
generated in a manner analogous to the above mentioned complementation constructs.
The PikAIII-PikAIV DD was amplified with primers PikA3A4 DD For (5’68

CACGAGGCGTACCTCGCAC- 3’) + PikA3A4DD Rev (5’CCGGATTCCGCCCGCGAA – 3’) from template pDHS0031 (D.H. Sherman,
unpublished). The PCR program consisted of an initial hold for 2 minutes at 94°C,
followed by 30 cycles of 94 °C for 30 seconds, 58 °C for 30 seconds, 72 °C for 1
minute. This was followed by a final extension period at 72 °C for 5 minutes. The
PCR products were purified and cloned into TOPO GW cloning kit (Invitrogen)
yielding pJY101. The apramycin aac(3)IV resistance marker was amplified from
pIJ773 (66), using primers PikA3A4DD apra rec For (5' - GCC CTG ATC CGG ATG
GCT CTC GGC CCC CGT AAC ACC TGA GTA *TAC GGT TCA TGT GCA
GCT CCA TC – 3') + PikA3A4 apra rec Rev (5' - TGC GCG GGA TGC GCG GGG
TGC GGC GCG TGG GGC AGG ACC GTA *TAC TGT AGG CTG GAG CTG
CTT C – 3'), (bold sequences represent annealing sites for the antibiotic marker and *
indicates the locations of Bstz17I restriction sites introduced for later removal of this
marker). The PCR program consisted of an initial hold at 94 °C, for 2 minutes,
followed by 10 cycles of 94 °C for 45 seconds, 55 °C for 30 seconds, 72 °C, for 1
minute. This was followed by another 15 cycles of 94 °C for 45 seconds, 58 °C for 30
seconds, 72 °C for 90 seconds. This was followed by a final extension period at 72°C
for 10 minutes. The resulting PCR product was again recombined as described above
with pJY101 via established procedures. The resulting recombinant plasmid pJY102
was isolated with the GeneJET Plasmid Miniprep Kit (Fermentas) and confirmed by
sequencing. Construct pJY102 was used as a template to generate a PCR product with
the needed 39nt complementary to the desired point of recombination between the
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linked ACP module1 and the KS of module 2 of DEBS1. PCR products for the
exchange of DNA sequences encoding the intramodular linkers between modules 1
and 2 for that coding for the PikAIII/PikAIV DD pair, were amplified with primer
pairs DEBS A3-A4 rec For (5' - CAC CCG ACT CCG CGT GCG CTC GCG GAA
GCA CTC GCG GCG CAC GAG GCG TAC CTC GCA CC - 3') + DEBS A3-A4
rec Rev (5' - GGG CAG CCG GCA GGC CAT CGC GAC GAC CGC GAC CGG
TTC TCC TGC CGA CGG TCG GCC CGG- 3') (primer sequences in bold
italicized font represent annealing sites on the template pJY102 and remaining 5’
region represent the complementary 39nt of the DEBS1 region for recombination).
The PCR program consisted of an initial hold at 94 °C for 2 minutes, followed by 10
cycles of 94 °C for 45 seconds, 52 °C for 45 seconds, and 72 °C for 90 seconds. This
was followed by another 15 cycles of 94 °C for 45 seconds, 58 °C for 45 seconds, and
72 °C for 90 seconds. This was followed by a final extension period at 72 °C for 10
minutes. PCR products were gel purified and introduced to pBK1 by homologous
recombination via established protocols. Recombinant pBK1 plasmids, were isolated
as before, treated with Bstz71I to remove the apramycin marker, ligated overnight at
12°C, transformed into E. coli. Single colonies were screened for both (+) Amp and () Apra, yielding pJY105.

3.3.4 Triketide lactone production analysis
Triketide lactone production was analyzed by a series of 10 mL SCM media
fermentations with the addition of thiostrepton (50 mg/L) of either BB138 or AX912
transformed with the appropriate DEBS1-TE expression plasmids (pBK1, pBK1*,
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pBK1**, pBK1* scar and pJY105). Fermentations were carried out at 30°C with
agitation (220 rpm) for 72 hours. After fermentation the entire culture media was
extracted 3X with 10 mL of ethyl acetate and dried. Extracts were treated with 200
µL of Trisil-Z (Pierce – Thermo Scientific) derivatization reagent for 20 minutes at
60°C to form their trimethyl silyl esters (TMS) derivative. Reactions were quenched
with 1 mL of water and allowed to cool to room temperature. The reaction was
extracted 3X with 1mL CHCl3. The collected CHCl3 extracts were concentrated to a
final volume of 0.5 mL. Derivatized extracts of BB138 or AX912 carrying the
appropriate plasmids were analyzed by GC-MS, on an Agilent Technologies 6890N
GC system along with an Agilent Technologies 5973 mass selective detector.
Triketides were identified by characteristic fragment ions at m/z = 73, 115, 130 and
M+ (dependent on starter unit).
Feeding experiments with cyclopropane, or cyclobutane carboxylic acids to S.
venezuelae carrying plasmid pBK1 or pBK1* were completed by first preparing an
overnight seed culture under the above described fermentation conditions. 100 µL of
this culture (1%) was added to fresh SCM media fermentations supplemented with
thiostrepton (50mg/L) and allowed to grow under normal conditions for approximately
10 hours. Carboxylic acids were added to a final concentration of 4mM and allowed
to continue growing under the previously described conditions.

3.3.5 DEBS ATL-ACPL expression and purification
The DEBS ATL-ACPL didomain was over expressed as a C-terminal His6tagged protein and purified from E. coli using the previously reported expression
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plasmid pBK12 (94). Expression was carried out in either BL21 DE3 chemically
competent cells (Invitrogen) or BAP1 cells. BAP1 E. coli cells are a derivative of
BL21 DE3 cells, which contains a chromosomally integrated copy of the sfp gene
encoding the requisite 4’-phosphopantetheinyl transferase, required for
posttranslational modification of the ACP domain to the holo form. BAP1 E. coli
cells were provided as a gift from Professor Chaitan Khosla’s laboratory, Stanford
University.
Overnight E. coli seed cultures harboring pBK12 were grown in LB medium
supplemented with 100 µg/mL ampicillin at 37°C with agitation. 1000 mL LB
medium cultures supplemented with ampicillin (100 µg/mL) were inoculated with 5%
(v/v) of the overnight seed culture and grown at 37°C with agitation to an O.D of
approximately 0.6 (approximately 2.5 hours). Cultures were allowed to cool to room
temperature and expression was induced by the addition of 0.5 mM isopropyl thio-βD-galactoside (IPTG). Cultures were allowed to grow for an additional 16 hours at
room temperature with agitation. Cells were harvested by centrifugation and either
stored at -80°C or immediately lysed for protein purification. His-tagged protein was
purified following the protocol outlined in Qiagen’s QiAexpressionist handbook under
native conditions with the following noted modifications. E. coli cells were resuspended in 25 mL of BugBuster Protein Extraction Reagent (Novagen). Cells were
disrupted by sonication and allowed to incubate on ice with slow agitation for at least
1 hour. The mixture was then subjected to centrifugation and the soluble fraction
(supernatant) was incubated with 1 mL of Ni-NTA agarose (Qiagen) on ice with
gentle agitation for at least 1 hour. The mixture was then transferred to a Polyprep
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Chromatography Column (BioRad) and allowed to equilibrate at 4°C. The cell free
extract (CFE) was drained and the Ni-NTA resin washed with 10 column volumes of
wash buffer 1 (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) followed
by 10 column volumes of wash buffer 2 (50 mM NaH2PO4, 300 mM NaCl, 20 mM
imidazole, pH 8.0). His-tagged protein was eluted from the Ni-NTA resin with 3mL
of elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0). 5
elution fractions were collected containing between 500-600 µL total volume. Each of
the 5 fractions along with the initial load, column flow through and the two column
washes were analyzed by SDS-PAGE gel electrophoresis using NuPAGE Novex 412% Bis-Tris gels (Invitrogen). Expression and purification was confirmed by the
presence of a large band between 50-75 kDa, DEBS ATL-ACPL has a molecular
weight of approximately 59 kDa. The target protein was further purified to
homogeneity by size exclusion chromatography using an AKTA FPLC System (GE
Health care, formally Amersham Biosciences) equipped with a Superdex GL 200
sizing column and a UV detector set at 280nm. Fractions containing the protein were
confirmed by SDS PAGE gel electrophoresis and concentrated with Amicon Ultra
Centrifuge columns (Milipore) and stored at -80°C for future use.

3.3.6 Radioactive labeling of DEBS ATL-ACPL
DEBS LD 14C radiolabeling experiments were carried with both apo and holo
ATL-ACPL using 14C propionyl and 14C isobutyryl CoA substrates purchased from
American Radiolabeled Chemicals. Both materials were supplied with specific
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activities of 50 µCi/µmol. DEBS LD (4 µM) was incubated under four different sets
of conditions: a) 14C propionyl CoA (100 µM) + unlabeled propionyl CoA (100 µM),
b) 14C propionyl CoA (100 µM) + unlabeled isobutyryl CoA (100 µM), c) 14C
isobutyryl CoA (100 µM) + unlabeled isobutyryl CoA (100 µM), d) 14C isobutyryl
CoA (100 µM) + unlabeled isobutyryl CoA (100 µM), all in 100 mM NaH2PO4, 1 mM
TCEP, 1 mM EDTA, 20% glycerol, pH 7.4. The extent of protein labeling was
determined by removing 25 µL aliquots at time points t= 0, 5, 7.5, 15, and 30 minutes.
Protein samples were precipitated with ice cold 10% TCA (400 µL) supplemented
with 40 µg of BSA, acting as a carrier protein. Samples were centrifuged at 14,500
rpm (14,000g) for 10 minutes, washed with another portion of 10% TCA (200 µL) and
centrifuged for an additional 5 minutes. Precipitated protein samples were resuspended in a solution of 2% SDS, 20 mM NaOH (50 µL) for liquid scintillation
counting.

3.3.7 Measurement of acyl CoA loading and hydrolysis by monitoring free CoA
formation
By monitoring the rates of protein dependent free CoA formation with
different acyl CoA substrates (acetyl, propionyl, isobutyryl) kcat and Km values were
determined for the apo form of DEBS ATL-ACPL. Free CoA formation was
monitored via a fluorescence assay using the commercially available thioglo reagent
from Covalent Associates Inc (Corvallis, OR) (Figure 18). Thioglo is a commercially
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available reagent, which derivitizes all free thiol containing compounds and fluoresces
when excited at 379nm.
Determination of kcat and Km values were completed in 3 sets of duplicate,
values averaged and standard error calculated. A mixture containing of 1.5 µM
protein was incubated at room temperature with varying concentrations of each
individual acyl CoA substrate (acetyl, propionyl, butyryl, isobutyryl) in a buffer
containing 100 mM NaH2PO4, 0.2 mM TCEP, 1 mM EDTA, 20% glycerol, at pH 7.4.
25 µL aliquots were removed after 30 minutes of incubation and placed in individual
wells of a 96 well plate pre-incubated on ice. The reactions were quenched by the
addition of 75 µL of DMSO. After all samples were collected and quenched, 100µL
of a 200 µM Thioglo stock solution (in DMSO) was added and the plate allowed to
incubate at room temperature with gentle agitation for approximately 25 minutes.
Alongside each set of experiments a standard curve was generated by preparing 0, 25,
50, 100, 200, and 400 µM free CoA in the same assay buffer followed by the same
work up procedure as described above. Excitation at 379 nm and emission monitoring
between 400 and 540 nm was completed with a Gemini EM Microplate
Spectrofluorometer (Molecular Devices), equipped with Softmax Pro software.
Maximum absorbance signal values were observed at 480 nm and were thus used to
correlate to a molar value of free CoA generated for each individual data point.
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Figure 18. Selective fluorescent properties of Thioglo melamide reagents. Only
after selective free thiol addition to the melamide ring does the conjugated aromatic
ring system exhibit fluorescence.

3.4 Results and Discussion
3.4.1 Substitution of Plm DD for intrapolypeptide linkers in DEBS1
Fermentations of BB138 harboring pBK1, pBK1*, pBK1**, and pBK1* scar
(Figure 21) were completed in at least two sets of triplicate to determine relative
quantities of triketide lactone (TKL) production. TKL production was confirmed and
quantified by GC-MS analysis. TKLs derived from acetate, propionate, and
isobutyrate were identified by their expected retention times and m/z values 157 (7.9
min), 171 (8.3 min), and 185 (8.5 min) respectively, corresponding to published data
for the expression of pBK1 in S. venezuelae (76) (Figure 19). In addition to each
individual M+ ion, TKLs were also identified by characteristic fragment ions with m/z
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values of 73 and 115 (Figure 20 a-c). Relative ratios of acetate, propionate, and
isobutyrate derived TKLs were determined by integration of the extracted ion
chromatogram GC peaks for each of the possible TKLs. Total amounts of TKLs
produced by the expression of the two separated constructs pBK1* and pBK1** were
45±15 and 40±4 % respectively when compared to the observed production by the
expression of pBK1 in BB138 (Figure 21). This approximate 50% reduction in total
production was comparable to the production level decrease observed in the dissected
pikromycin system described in chapter 2. This evidence has provided further
evidence that multimodular PKS polypeptides can be separated with DDs without a
significant drop in overall production.
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Figure 19. GC-MS total ion chromatogram of an extract of S. venezuelae (BB138)
carrying pBK1. Expected TKL lactone products derived from acetate, propionate,
and isobutyrate elute at 7.9, 8.3 and 8.5 minutes respectively.
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Figure 20a. Ions associated with acetate-derived TKL. Labeled m/z values of 157,
represent the acetate-derived TKL molecular ion, while 73 and 115 represent
characteristic fragment ions.
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Figure 20b. Ions associated with propionate-derived TKL. Labeled m/z values of
171 represent the propionate-derived TKL molecular ion, while 73 and 115 represent
characteristic fragment ions.
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Figure 20c. Ions associated with isobutyrate-derived TKL. Labeled m/z values of
185 represent the isobutyrate-derived TKL molecular ion, while 73 and 115 represent
characteristic fragment ions.
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Figure 21. Triketide lactone production levels for DEBS1-TE expression
constructs pBK1, pBK1*, pBK1** and pBK1* scar expressed in BB138.
Percentage values for each of the observed acetate (A), propionate (P), or isobutyrate
(IB) derived TKL products were determined by integration of GC peaks from the
extracted ion chromatogram of each product. Total TKL percentage values for
fermentations of BB138 carrying pBK1*, PBK1** and pBK1* scar are relative values
compared to that produced by intact DEBS1-TE (pBK1).
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3.4.2 Expression of pBK1* in BB138 results in a shift in TKL ratios
Published reports have shown that the loading domain of DEBS possess some
relaxed substrate specificity; however in these reports the preferred starter unit has
consistently remained propionate (54, 80, 84, 97). Based on this previous work, the
dramatic shift from the propionate-derived product in favor of the isobutyrate derived
TKL in fermentations of BB138 harboring pBK1*(Figure 22) is an intriguing
unexpected observation.
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Figure 22. GC-MS total ion chromatogram of an extract of S. venezuelae (BB138)
carrying pBK1*. Expected TKL lactone products derived from acetate, propionate,
and isobutyrate elute at 7.9, 8.3 and 8.5 minutes respectively.
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Published evidence has shown that strains of Saccharopolyspora erythraea
where DEBS ATL-ACPL has been deleted still retain the ability to produce
erythromycin, albeit at a much diminished level (98). This evidence of direct KS
domain loading made it essential to determine if the observed shift in TKL ratios arose
through the change in expression of DEBS ATL-ACPL as a stand-alone protein and not
simply the direct loading of DEBS KS1 with isobutyrate. This was achieved by
constructing an ATL-ACPL deletion variant of pBK1, pBK1* scar (analogous to
pJY7* scar described in chapter 2) with the C-terminal Plm DD fused to the Nterminal of KS1. Fermentations of BB138 caring pBK1* scar, which expresses
DEBS1-TE without the ATL-ACPL retained the ability to produce TKLs at
approximately 2% of that observed for intact DEBS1-TE. Furthermore, nearly 90% of
the observed TKL products were propionate-derived (Figure 23). This observation
confirms previous published data that mutant strains lacking the ATL-ACPL can still
function and produce polyketide products, however with a significant drop in overall
production (98). These observations indicate two additional points: a) that the KS of
DEBS module 1 has the ability to be directly acylated by acyl CoAs in the absence of
the naturally interacting ACP domain, and b) the KS domain has a strong preference
for accepting and processing propionate into the final product. This observation
confirms that the majority of the isobutyrate-derived TKL observed in fermentations
of BB138/pBK1* can be attributed to the activity of the separated DEBS ATL-ACPL,
presenting the isobutyrate starter unit to the KS of module 1 for TKL production.
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Figure 23. Extracted ion chromatogram of BB138 fermentation carrying
expression construct pBK1* scar. Ions with m/z values of 157, 171, and 185
corresponding to acetate, propionate and isobutyrate derived TKLs were selectively
extracted from the total ion chromatogram. Propionate derived TKL with the expected
retention time of 8.3 minutes was the only major product produced by the expression
of this ATL-ACPL deletion construct. Due to the low levels of TKL production with
the expression of pBK1* scar, the ions associated with each TKL were only detectable
under selected ion monitoring conditions.
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3.4.3 Impact on TKL production for the module1- module 2 separation
In order to thoroughly analyze the impact on polyketide production when the
DEBS1-TE multimodular polypeptide is separated with matched docking domains,
this polypeptide was also separated at the module 1-module 2 junction yielding
expression construct pBK1**. This construct expresses DEBS1-TE with the Plm DD
pair at the module1-module 2 junction and was generated in an analogous fashion to
pJY7 described in chapter 2. As expected, expression of pBK1** in BB138 resulted
in 40±4% total TKL production compared with pBK1 as observed by GC-MS
analysis. Expression of DEBS1-TE now separated with the PLM DD pair between
modules 1 and 2 resulted in a predominance in the propionate derived TKL (59%)
comparable to the relative ratios observed with the expression of intact DEBS1-TE
(67%) (Figure 24). The percentage of the isobutyrate derived TKL was 26% of the
total TKLs for the expression of pBK1, lower than the 67% observed with the
expression of pBK1* but higher than the 11% observed with pBK1 expression.
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Figure 24. GC-MS total ion chromatogram of an extract of S. venezuelae (BB138)
carrying pBK1**. Expected TKL lactone products derived from acetate, propionate,
and isobutyrate elute at 7.9, 8.3 and 8.5 minutes respectively. Although the peaks
associated with the propionate (8.3 minutes) and isobutyrate (8.5 minutes) derived
TKL appear equivalent, selected ion monitoring and integration for m/z values of 171
and 185 for the respective TKLs showed at least a two fold larger production of
propionate versus isobutyrate-derived TKL.
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3.4.4 Expression of DEBS1-TE constructs in AX912
Expression of pBK1 and the above described variants (pBK1* and pBK1**) in
S. venezuelae (BB138) results in the efficient and predictable production of TKL
products. However the dramatic shift in TKL production ratios for the expression of
pBK1*, when the ATL-ACPL is expressed as a stand-alone protein, separate from the
first and second extension module was not expected. An initial hypothesis to explain
this shift, involved the activity of the pikromycin thioesterase II (Pik TE II), which is
encoded with the other Pik PKS genes in S. venezuelae (BB138). Previously
published data on the Pik TEII enzyme has assigned its probable role as a
housekeeping enzyme. This work provided in vitro evidence that Pik TEII is capable
of cleaving specific acyl groups from both DEBS ATL-ACPL and PikAIII (Figure 5a)
with varying efficiencies depending on the attached acyl group (94). A delayed
transfer of the starter unit from the ACPL to KS1 of DEBS1-TE might permit
preferential removal of a propionyl group from ACPL, giving rise to the increase in
isobutyrate-derived TKLs. To test this hypothesis, the above-described DEBS1-TE
expression constructs were transformed and expressed in AX912, a Pik TEI and TEII
deletion strain of S. venezuelae (65). TKL production was again screened for as
before with fermentations of BB138 using GC-MS analysis. Again expression of
pBK1 resulted in a predominance of the propionate derived TKL (61% of total TKLs)
(Figure 25), while expression of pBK1* resulted in a nearly an equal ratio of the three
observed TKLs (Figure 26). A summary of triketide lactone production for the
expression constructs pBK1, pBK1* and pBK1** are summarized in Figure 27. As
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the isobutyrate-derived TKLs still predominate, a factor other than Pik TEII must
account for the shift in TKL ratios.
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Figure 25. GC-MS total ion chromatogram of an extract of S. venezuelae (AX912)
carrying pBK1. Expected TKL lactone products derived from acetate, propionate,
and isobutyrate elute at 7.9, 8.3 and 8.5 minutes, respectively.
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Figure 26. GC-MS total ion chromatogram of an extract of S. venezuelae (AX912)
carrying pBK1*. Expected TKL lactone products derived from acetate, propionate,
and isobutyrate elute at 7.9, 8.3 and 8.5 minutes, respectively.

90

OH

O

pBK1

pBK1*

pBK1*!"

A
23.6±3.9

OH

OH

O

O

O

O

O

% production
P
61.1±6.3

IB
Total
15.4±10.1 100

34.7±8

31.1±3.5

33.9±11.2 40±8

18.9±0.5

52.2±10.1 28±10.4

30±4

Figure 27. Triketide lactone production levels for DEBS1-TE expression
constructs pBK1, pBK1*, and pBK1** expressed in AX912. Percentage values for
each of the observed TKL products acetate (A), propionate (P), or isobutyrate (IB)
derived were determined by integration of GC peaks from the extracted ion
chromatogram of each product. Total TKL percentage values for fermentations of
BB138 carrying pBK1* and PBK1** are relative values compared to intact DEBS1TE (pBK1).
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3.4.5 PikAIII-PikAIV DD: PJY105 expression in YJ004
In addition to the Plm DD pair that has been utilized to separate multimodular
PKS polypeptides, an additional pair that is naturally present between PikAIII and
PikAIV of the Pik PKS was also used to separate DEBS1-TE. Construct pJY105 was
designed to express DEBS1-TE in the same exact manner as pBK1*, except that the
DD pair from between PikAIII and PikAIV substituted for the intrapolypeptide linker
between the loading domain and module 1. Initially expression of this construct was
completed, as before in the PikAI deletion strain BB138, however fermentations
generated no detectable TKL products. One possible explanation, was that there
maybe an unintended docking interaction between the PikAIII-PikAIV DD pair now
present between the loading domain and module 1 of DEBS 1-TE and modules 5 and
6 of the Pik PKS (Figure 5a), since the encoding region for PikAIII and PikAIV are
present on the chromosomal DNA of BB138. Potential docking interactions between
DEBS ATL-ACPL and module 6 of Pik and module 5 of Pik with DEBS module 1,
might lead to the loss of TKL production. Given this possibility pJY105 was
alternatively expressed in a PikAIII-PikAIV deletion strain of S. venezuelae, YJ004
(65), alongside pBK1 as the positive control. The expression of pJY105 in YJ004
resulted in trace levels of TKL production, which were approximately 1% of the wild
type control experiment (expression of intact DEBS1-TE in the same strain of S.
venezuelae).
This result using the PikAIII-AIV DD pair is in stark contrast to the
approximately 50% production that is retained when the Plm DD pair were utilized.
The drastic drop in production for the expression of pJY105 compared to pBK1* and
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pBK1** supports the conclusions from chapter 2 (lack of production for the
expression of pJY9, where no docking domains are present) that docking domain are
important but also infers that the specific docking domains are necessary to retain the
ability of dissected PKS polypeptides to produce polyketide products. The basis for
the ability of one DD pair to provide the necessary protein-protein interactions for the
passage of polyketide intermediates over another is not clearly evident. Based on
published data specifically describing the PikA3 and PikA4 docking interactions (40),
it has been shown that the binding specificity which docking domains display for one
another can be increased dramatically by the presence of the extended downstream
protein sequences, in this case the entirety of Pik module 6. This data supports the
notion that docking domains are important for the proper protein-protein interactions
required for polyketide biosynthesis; however there are additional intrinsic
specificities which direct a module to properly interact with its cognate partner in the
biosynthetic process which lie in the downstream KS-AT region that has yet to be
determined (99, 100). Given these data, there are two possible explanations for the
lack of production when this set of DDs were used to dissect DEBS1-TE. One
possible explanation is that this DD pair perturbs the natural ACP-KS interactions,
which play key roles in the proper module-module interactions. A second possible
explanation is that the N-terminal DD which has been fused upstream of the KS
domain does not facilitate the adequate expression and proper folding of a functional
protein for polyketide production.
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3.4.6 Incorporation of cyclic unnatural starter units
Previous feeding experiments with the DEBS PKS have shown that this system
has the ability to not only incorporate a wide variety of naturally available starter units
but is also able to utilize certain unnatural cyclic acyl groups when fermentation
cultures are supplemented with the corresponding carboxylic acids (56). This
observation was the result of a control experiment for a modified DEBS producing
strain of S. coelicolor, where the loading domain for the production of avermectin
from S.avermitilis was exchanged with the DEBS loading domain. It was understood
that the avermectin loading domain could process a wide range of starter units
including cyclic and branched chain acyl groups (86). The goal of the loading domain
exchange was to utilize this loading flexibility to generate novel erythromycin
analogs. While their experiment with this hybrid system was successful in generating
novel erythromycin analogs, when cyclopropane and cyclobutane carboxylic acids
were feed to the control experiment (wild type DEBS system) the same cyclic starter
unit derived erythromycin analogs were unexpectedly observed.
Guided by the observation that the DEBS PKS is able to utilize some cyclic
starter units, it was examined if feeding to fermentations of S. venezuelae expressing
the separated DEBS ATL-ACPL from module 1 would result in a higher ratio of the
novel cyclic acyl group derived TKL products than the intact DEBS1-TE protein.
This possibility was explored because the expression of the dissected DEBS1-TE
construct (expression of pBK1*) resulted in unexpectedly higher levels of the
isobutyrate-derived TKL compared to intact DEBS1-TE. Fermentations of BB138
harboring either pBK1 or pBK1*, supplemented with either cyclopropane or
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cyclobutane carboxylic acid were completed in triplicate. Fermentations were
analyzed by GC-MS analysis alongside selected ion monitoring for the expected m/z
values of the M+ masses of the expected compounds, 183 and 197 respectively for
cyclopropane and cyclobutane derived TKLs (Figure 28). Masses with the predicted
m/z values of 183 and 197 were observed in both fermentations of BB138/(pBK1 or
pBK1*) at 9.5 and 10.1 minutes respectively. Production levels of the unnatural
cyclic carboxylic acid derived TKLs were not significantly different for the expression
of pBK1* compared to pBK1.

a

b

OH

O

O

Figure 28. Production of TKLs derived from cyclic starter units. Extracted ion
chromatogram for a) cyclopropane-derived TKL, m/z 183 at 9.5 min and b)
cyclobutane-derived TKL, m/z 197 at 10.1 min.
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3.4.7 Hypothesis for the shift in production to favor isobutyrate-derived TKL
with the dissection of the DEBS ATL-ACPL
The above described data where the expression of pBK1* scar (Figure 23)
results in a drastic drop in TKL production but a majority of the production is derived
from the propionate starter unit, indicates two important factors; one is that the ATLACPL is required for efficient polyketide production and the second is that the shift to
favor the isobutryrate-derived TKL product is the result of the DEBS ATL-ACPL
domain presenting the KS of module 1 with the isobutyrate starter unit. In vitro
observations in the Reynolds lab has shown that a variety of PKS proteins, when
incubated with acyl CoA substrates can result in an increase of free CoA concentration
over time and the rate of free CoA formation is dependent on the acyl CoA substrate.
Given these observations it has been hypothesized that once an acyl group has been
loaded onto the AT domain of the loading module, the group can be hydrolyzed. Thus
the AT domain acts as a thioesterase, consuming acyl CoA substrates.
Given this information, one hypothesis to explain the shift in TKL ratios for
the expression of pBK1* was that there are differences in the rates of hydrolysis for
different acyl groups bound to DEBS ATL-ACPL. In this model, propionate and
isobutyrate load onto DEBS ATL-ACPL with comparable rates as an intact protein,
however propionate would be hydrolyzed much faster, leaving isobutyrate to be
passed onto the KS of module 1 for polyketide processing. In this hypothesis, the
assumption was that the normal polyketide biosynthetic process is relatively fast,
where intermediates are efficiently passed from one protein active site to the next and
that the hydrolytic activity of the AT domain is thus not significant. However when
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the protein biosynthetic machinery is separated as in the constructs described in this
thesis (pJY7, pJY12, pBK1*, pBK1**) the resultant production levels are
approximately 50%, which is presumably due to the fact that PKS proteins separated
with DDs result in a decreased efficiency in the passage of biosynthetic intermediates.
A decrease in passage efficiency of intermediates would presumably result in
covalently bound acyl groups to exist on the protein and would result in a greater role
of hydrolytic process determining TKL product ratios.
In order to examine the dynamics of hydrolysis for different acyl groups from
DEBS ATL-ACPL, this protein was expressed and purified from E. coli for further in
vitro studies. DEBS ATL-ACPL was purified as a C–terminal His tagged protein from
E. coli harboring the previously described expression construct, pBK12 (94). Initial
purification of this protein (in both the apo and holo) using Ni-NTA resin yielded
large quantities of soluble protein, however the high degree of impurities required
further purification, which was accomplished via size exclusion chromatography
(Figure 29).
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a)

L FT w1 w2 E1 E2 E3 E4 E5

~75 kDa

His tagged DEBS
ATL-ACPL
~59 kDa

~50 kDa

b)
c)

13 14

Purified
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Figure 29. Expression and purification of DEBS ATL-ACPL (apo and holo). a)
SDS PAGE gel of Ni-NTA resin purified protein (M-molecular weight marker, Lmaterial loaded on Ni-NTA resin, FT-flow through, W1-W2 – washes, E1-E5 –
elution fractions. b) Size exclusion FPLC chromatogram of Ni-NTA purified protein,
DEBS ATL-ACPL eluted in factions 13 and 14. c) SDS PAGE gel of fractions
containing partially purified protein after size exclusion chromatography.
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3.4.8 Kinetic analysis of DEBS ATL-ACPL with varying acyl CoA substrates
Kinetic parameters (kcat and Km) for the apo form of DEBS ATL-ACPL were
determined by monitoring the protein dependent formation of free CoA with three
different acyl CoA substrates (acetyl, propionyl, and isobutyryl) under pre-optimized
linear conditions (Figure 30). Apo DEBS ATL-ACPL kcat and Km values with each
substrate are summarized in Table 1.

b) Propionyl CoA

a) Acetyl CoA
2.5

2.0

2.0

1.5

1.5
1.0

1.0
0.5
0.0

0.5
0

1000

2000

3000

4000

0.0

5000

0

1000

[Acetyl CoA] (µ!)

2000

3000

4000

5000

[Propionyl CoA] (µM)

c) Isobutyryl CoA
3.0
2.5
2.0
1.5
1.0
0.5
0.0

0

1000

2000

3000

4000

5000

[Isobutyryl CoA] (µ!)

Figure 30. Kinetic analysis of apo DEBS ATL-ACPL with a) acetyl CoA, b)
propionyl CoA, and c) isobutyryl CoA
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Table 1. Kinetic parameters for DEBS ATL-ACPL

Substrate

kcat (s-1)

Acetyl CoA
Propionyl CoA
Isobutyryl CoA

1.3 ± 0.1
1.5 ± 0.1
2.1 ± 0.1

kcat/Km
(mM-1 s-1)
812 ±102 1.6
360 ± 54 4.2
486 ± 92 4.4
Km (μM)

Kinetic parameters were determined using the apo form of the protein, which allowed
for the acylation and subsequent hydrolysis off of the AT domain to be specifically
examined. Since these kinetic parameters were determined by the increase in free
CoA concentration, which is dependent on both the rate constants of acylation (kA)
and hydrolysis (kH) the observed kcat values are dependent on both of these process.
The kcat value can be described an extension of the standard Michaelis-Menton model
by the equation kcat=(kA*kH)/(kA+kH) (101).
The approximately equivalent catalytic efficiency of DEBS ATL-ACPL for the
processing of propionyl and isobutyryl CoA, as determined by kcat/Km values of 4.2
and 4.4 mM-1 s-1 respectively do not reflect any significant difference in hydrolytic
rates. The observed kinetic data for DEBS ATL-ACPL, demonstrate that there is not a
slower rate of hydrolysis for isobutyrate versus propionate from the AT domain and
that there must be another basis to explain the dramatic shift in TKL production for the
expression pBK1* when compared to pBK1.
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3.4.9 Radioactive acylation of DEBS ATL-ACPL
The preceding experiments demonstrate that the shift in TKL ratios favoring
the isobutryrate-derived product can not be explained by a slower hydrolytic rate for
isobutyrate versus propionate or a preferential TEII catalyzed removal of propionate
from ACPL. Thus an alternative explanation was sought. The DEBS ATL-ACPL
recombinant protein was examined under a series of in vitro 14C radioactive acyl CoA
labeling experiments. The goal of this work was to determine the rate of AT domain
acylation and subsequent transfer to the ACP domain for propionate and isobutyrate
when only one substrate was present. The extent of 14C labeling for the apo protein
was used to determine the rate of AT domain acylation, while experiments with the
holo protein resulted in information about the transfer of acyl groups from the AT to
the ACP domain. In addition, competition experiments where both substrates were
present was used to track changes in protein labeling from the different acyl CoA
substrates as a function of time.
Incubations of the DEBS ATL-ACPL were carried out under 4 separate sets of
conditions, utilizing propionyl and isobutyryl CoA labeled material mixed with non
radioactive material; a) 14C propionyl CoA + unlabeled propionyl CoA (hot/cold P), b)
14

C propionyl CoA + unlabeled isobutyryl CoA (hot P/cold IB), c) 14C isobutyryl CoA

+ unlabeled isobutyryl CoA (hot IB/cold P), d) 14C isobutyryl CoA + unlabeled
isobutyryl CoA (hot/cold IB). As with the above described kinetic analysis, the apo
form of the protein was initially utilized, this allowed the dynamics of the AT
acylation and hydrolysis to be examined specifically without the additional
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complication of the dynamic AT-ACP transfer step. Aliquots of each individual
reaction were removed over time and the protein was then precipitated and washed to
remove any excess radioactive materials before liquid scintillation counting (LSC).
LSC measurements in disintegrations per minute (DPM) were converted to mole
values by use of the specific activity of the radioactive material in each experiment to
determine the concentration of acylated protein at each time point. Initial work with
the apo protein under the above described conditions with either propionyl or
isobutyryl CoA (equal molar mixture of 14C labeled and unlabeled) alone resulted in
an unexpected result (Figure 31a). Throughout the time course of this experiment the
amount of recovered labeled protein was significantly higher in the presence of
isobutyryl CoA (approximately 1.5 µM / 37% of maximum) compared to propionyl
CoA (approximately 0.4 µM / 10% of maximum). These observed differences in the
levels of labeling can be rationalized by either: a) propionate loading onto the AT
domain and being subsequently hydrolyzed at a much faster rate than isobutyrate, or
b) that isobutyrate loads onto the AT domain of the protein at much faster rate than
propionate.
Given that the overall rate of hydrolysis for each substrate are known, the
levels of acylated protein in these experiments permitted a calculation of the specific
acylation and hydrolytic reaction rates to be modeled (Chris Hazzard, personal
communication). This model assigned specific values for the rate constants for both
AT domain acylation (kA) and hydrolysis (kH) for both substrates, propionate and
isobutyrate based on the experimental observation with the apo protein and single acyl
CoA substrates (Figure 32) (Chris Hazzard, unpublished data). In this model the
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kinetic parameters and assigned kA and kH values were fitted to a remarkable and
accurate description of the experimentally observed labeling data for both the apo and
holo protein (Figure 31c-d). These kinetic values (Figure 32) show that isobutyrate
loads faster than propionate but is hydrolyzed from the AT domain at a slower rate.
As such the level of labeled protein is higher with isobutyryl CoA than with propionyl
CoA as the substrate. Given that the overall rates of hydrolysis for isobutyrate and
propionate are similar, the observed kinetics for the apo protein do not provide a
sufficient explanation for the observed shift in TKL production when the DEBS ATLACPL is separated from the first and second extension modules of DEBS1.

a) Experimental apo
DEBS ATL-ACPL labeling

5

2.5

4

2.0

3

1.5

[ATL-ACPL -P]
[ATL-ACPL -IB]

1.0

[ATL-ACPL -P]
[ATL-ACPL -IB]

2
1

0.5
0.0

b) Experimental holo
DEBS ATL-ACPL labeling

0
0

10

20

30

40

0

10

c) Model of apo
DEBS ATL-ACPL labeling

1.5
1

30

40

[ATL-ACPL-IB]

d) Model of holo
DEBS ATL-ACPL labeling

3.0

µM labeled protein

µM labeled protein

2

20

time (min)

time (min)

[ATL-ACPL-P]

0.5
0

2.5
2.0

[AT-ACP-P]

[AT-ACP-IB]

1.5
1.0
0.5
0.0

0

2

4

6

time (min)

8

10

0

5

10

15

20

25

30

time (min)

Figure 31. Experimentally determined and kinetic model predicted levels of
DEBS ATL-ACPL labeling with 14C propionyl or isobutyryl CoA.
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Figure 32. Proposed dynamics of propionyl and isobutyryl CoA loading and off
loading on DEBS ATL-ACPL. A faster acylation of the AT domain is observed with
isobutyryl than propionyl CoA. However, formation of the propionyl-ACPL is
favored over isobutyryl-ACPL as a result of differences in the AT-ACP transfer rates
for the two different acyl groups.
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A similar series of analyses were conducted with the holo form of DEBS ATLACPL. Examination of this form of the protein under the same conditions as the apo
protein resulted in increases of recovered 14C labeled protein with both propionyl and
isobutyryl CoA substrates (Figure 31b). The concentration of labeled protein
increased to approximately 2µM (25% of maximum) and 3 µM (37% of maximum)
with propionyl and isobutyryl CoA respectively. This increase is logical since the
ACP domain is able to bind acyl substrates when post-translationally modified. The
higher levels of 14C labeling for the holo protein compared to the apo, provide
important insights into the dynamics of acyl group loading onto the AT domain and
the subsequent passage to the ACP domain. The increase of 14C labeling for propionyl
CoA with the holo protein versus the apo form signifies that the majority of the
observed labeling arises from covalent attachment to the ACP domain and not the AT.
Conversely the small increase in labeling with isobutyryl CoA from 2 to 3µM
indicates that with isobutyryl CoA, the majority of the protein bound acyl group is on
the AT and not the ACP domain. Furthermore, the increase in isobutyryl CoA
labeling is not observed during the initial time points of the experiment, but is with
propionyl CoA. These observations indicate that the transfer of isobutyrate from the
AT to the ACP domain is slow relative to the same process for propionate.
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3.4.10 Acyl CoA competition experiments
The next question that was explored involved examining the behavior of DEBS
ATL-ACPL in the presence of competing acyl CoA substrates. Radioactive acyl CoA
competition experiments with combinations of 14C propionyl CoA with unlabeled
isobutyryl CoA (hot P/cold IB) and 14C isobutyryl CoA with unlabeled propionyl CoA
(cold P/hot IB) with both the apo and holo form were carried out and analyzed as
previously described (Figure 33). The trends from the competition experiments with
the apo protein displayed similar results to the above described assays when single
substrates were present. Despite a drop in the maximum observed labeling, these
results again show higher levels of AT labeling with 14C isobutyrate and lower levels
of labeling with 14C propionate, despite the presence of a competing substrate. This
result shows that even in the presence of competing substrates, isobutyrate is
preferentially loaded on the AT domain at much higher levels than propionate (Figure
33a). These results agree with the hypothesis that isobutyrate loaded on the AT
domain is the kinetically favored product versus propionate.
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Figure 33. Experimentally observed levels of DEBS ATL-ACPL labeling with
competing acyl CoA substrates (propionyl and isobutyryl CoA) for a) apo and b)
holo forms of the protein.
Experimental data from the competition experiments utilizing holo DEBS
ATL-ACPL provided insight regarding the placement of acyl groups, either on the AT
or ACP domain of the protein. These experiments indicate that when 14C propionyl
CoA and unlabeled isobutyryl CoA were incubated with the holo protein, the
maximum level of labeling was observed at time=0, however over the time course of
the experiment the levels of labeled protein was reduced by approximately 50%
(Figure 33b). Conversely when 14C isobutyryl CoA and unlabeled propionyl CoA
were incubated with the protein, the levels of labeled protein increase by
approximately 40% over the time course of the experiment.
Acyl CoA competition experiments with the holo and apo data clearly
indicates that when 14C propionate is present, the majority of the labeled protein is the
result of attachment to the ACP domain specifically and not the AT. The observed
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decrease in labeling over the time course of this experiment can be attributed to a
combination of two possible processes. The first is the replacement of 14C propionate
on the AT with unlabeled isobutyrate but can be discounted by the knowledge that
these levels are low (see experiments with the apo protein and propionyl CoA). A
second more reasonable explanation involves the dynamic equilibrium for ACP bound
acyl groups, in this case propionate on the ACP domain (Figure 16c) can be passed
back to the AT where hydrolysis of the acyl group can take place (Figure 16b). In this
process the labeled propionate group can be replaced by unlabeled isobutyrate and the
system can move from the kinetic product (propionyl ACPL) to a thermodynamic
equilibrium consistent with this hypothesis.
The observations with 14C isobutyryl and unlabeled propionyl CoA along with
the apo data suggests that at time=0, the majority of the observed labeling in the
competition experiment is the result isobutyrate on the AT domain. However over the
duration of the experiment, an increase in the concentration of labeled protein was
observed, which likely represents the transfer of isobutyrate from the AT to the ACP
domain. The combined labeling data for both the apo and holo forms of DEBS ATLACPL with either single or competing substrates has provided a model which explains
the shift in TKL ratios for the separation of DEBS ATL-ACPL from the first and
second extension modules of DEBS1.

3.4.11 Correlation of in vitro and in vivo results
Based on the in vivo data for the expression of pBK1* scar, the source of the
shift in starter unit preference away from propionate and towards isobutyrate has been
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attributed to the DEBS ATL-ACPL di-domain presenting the KS of module 1 with a
higher ratio of isobutyrate than propionate. This in vivo change over in the acyl group
that is bound to the loading domain ACP and being presented to the KS of module 1 is
also observed in vitro. The change which is observed in the holo DEBS ATL-ACPL
competition labeling experiments from an initial predominance in propionate to
isobutyrate (Figure 33b) over the time confirms the in vivo observation and supports
the hypothesis that over time a stand alone protein, as in the in vivo expression of
pBK1*, results in higher levels of isobutyrate on the ACP domain.

3.5 Conclusion
The biosynthetic process for type I modular polyketide synthases involves the
selection of a starter unit by the loading module AT, which is passed to the cognate
ACP domain. Once a starter unit is on the ACP it is then passed to KS domain of the
first extension module for the first round decarboxylative condensation with the preselected extender unit. In a multimodular system the passage of biosynthetic
intermediates is a relatively fast and efficient process. However as was observed in
the pikromycin PKS described in chapter 2 and the DEBS PKS in this chapter, when
multimodular PKS polypeptides are separated with DD pairs there is a drop in the
biosynthetic efficiency. One of the reasons for this drop can be attributed to the
slower passage of intermediates. This decrease in biosynthetic efficiency would leave
intermediates bound to the preceding module’s ACP and or AT domains susceptible to
either thioesterase activity or hydrolysis and would allow for the build up of
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intermediates that are not the normal kinetic product. In the case of the DEBS PKS,
when the loading module is separated from the first and second extension modules, the
slower passage of the starter unit from the ACP domain to the KS of module 1, has
allowed for the accumulation and predominance of isobutyrate bound to the ACP in
place of propionate.
The observed shift in starter unit incorporation by the DEBS PKS when the
loading module has been separated from the rest of DEBS1 is quite remarkable and
adds much insight into the dynamics of modular PKS enzymes. The shift towards
isobutyrate TKLs along with the above described in vitro data clearly indicate that AT
domain acylation and AT-ACP transfer are dynamic processes. By slowing down and
reducing the efficiency at which the ACP of the loading module passes the starter unit
to the KS of module 1, it has been revealed that loading module ACP domains can
present an unexpected starter unit, which normally does not predominate. These
insights into the dynamics of acyl group loading and incorporation into the polyketide
product, add another level of consideration which must be accounted for when
designing hybrid and genetically modified PKS enzyme systems.
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4. In vitro investigation of the iterative mono module BorA5 from the
borrelidin PKS from Streptomyces parvulus Tu4055

4.1 Summary
The PKS responsible for the biosynthesis of borrelidin consists of a loading
domain and six extension modules, which are housed on six separate polypeptides.
The loading domain along with each of the six extension modules are contained on
their own polypeptide, with the exception of modules 2 and 3 which are contained on
the dimodular single protein, BorA3. Despite the non-iterative nature of most type I
modular PKS modules, BorA5 has been proposed to be unusual, acting iteratively by
incorporating three molecules of methylmalonyl CoA into the final polyketide
structure. In vitro examination of this module was accomplished by cloning,
expressing and purifying the entire PKS module as well as specific domains using E.
coli as an expression host. This work has shown that some of the catalytic domains of
BorA5 can be expressed as separate proteins and can act in trans with one another.
Specifically, this work has demonstrated by mass spectrometric (MS) analysis that
when expressed as a stand-alone protein, the BorA5 ACP domain in the holo (with the
4’-phosphopantetheine group attached) form can be acylated with methylmalonyl CoA
substrate in the presence of the entire BorA5 protein. This work has laid the
groundwork and basis for additional in vitro studies of the BorA5 iterative module by
monitoring specific reactions on the stand-alone BorA5 ACP domain.
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4.2 Introduction
The structure of the macrocyclic polyketide natural product borrelidin (Figure
31) from Streptomyces parvulus Tu4055 was elucidated in 1967 (102). Initially
borrelidin was discovered for its antimicrobial activity (103, 104), but has since also
been reported to have antiviral (105) and antiangiogenesis (106) activities. The gene
cluster responsible for borrelidin biosynthesis from Streptomyces parvulus Tu4055
was cloned, sequenced and reported in 2004 (107). The structure of borrelidin has two
features not commonly observed in polyketide products; 1) the starter unit for
biosynthesis is trans-cyclopentane (1R, 2R)-dicarboxylic acid and 2) a nitrile group at
C12 of the borrelidin structure (Figure 34). Additionally the borrelidin PKS is unusual
in that it does not follow the general rule of one extension step per module.
Specifically, BorA5 has been proposed to function in an iterative fashion, catalyzing
three rounds of polyketide chain elongation. The presence of an iterative module in an
otherwise modular type I bacterial PKS systems has also been observed in the
aureothin system from Streptomyces thioluteus (47). Iterative PKS activities are
typically observed in type II and type III PKS systems described in chapter 1 but are
quite rare in type I PKSs.
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Figure 34. Modular organization of the borrelidin PKS

The borrelidin PKS modular organization (Figure 34) consists of a loading
domain and six extension modules that have been proposed to carry a total of eight
elongation cycles. Based on the structure of the final product and module organization
of the borrelidin PKS, it has been proposed (46) that BorA5 functions iteratively,
catalyzing three successive rounds of elongation using methylmalonyl CoA extender
units with full reduction of C4-C9 to methylene moieties. If BorA5 is responsible for
multiple condensation steps, it is logical to think that in between each round of
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elongation that BorA5 catalyzes, the growing polyketide chain is transferred from the
ACP domain back to the KS domain and that only after all three rounds of elongation
and modification (keto reduction, dehydration, and enoyl reduction) is the growing
chain passed to module 6 for further elongation and subsequent cyclization. Iterative
PKS modules represent a presumed relaxed substrate specificity, since the KS
domains of these modules are required to both accept and process polyketide chains of
different carbon length. This presumed relaxed substrate processing capacity of
BorA5 was the initial target of this study for its possible utilization in efficient hybrid
PKS systems capable of producing a variety of compounds.
The goal of this work entailed cloning and expressing BorA5 in E. coli as a
recombinant protein for in vitro studies. Initially the goal of this project involved
examining the flexibility of intact BorA5 to load and process different starter units for
subsequent polyketide chain elongation. In addition to this it was sought to examine if
these starter units would undergo one, two or three rounds of chain elongation and to
what extent there would be keto group reduction and dehydration. However, due to
limitations of the amount of BorA5 in the holo form, which could be purified, the
focus of this study shifted towards separating and expressing individual BorA5
domains. Examples of deconstructing an entire PKS module and expressing specific
functional domains as separate discrete proteins have been reported for both DEBS
module 3 from the erythromycin PKS (108) as well as PksA, which initiates
biosynthesis of the environmental carcinogen aflatoxin B1 (109-111). This work has
shown that multidomain PKS proteins can be functionally reconstituted as a
combination of proteins while retaining their respective catalytic functions.
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Deconstruction of BorA5 was attempted by cloning and expressing the
individual catalytic domains or combinations of domains and reconstituting them in
vitro with one another. Intact BorA5 in the apo form (without the phosphopantetheine
arm attached to the ACP domain) along with the ACP domain were successfully
expressed and purified from E. coli as N-terminal His6 tagged proteins. It has been
shown here that BorA5 ACP can be acylated with methylmalonyl CoA by the intact
apo BorA5 module. This preliminary work has thus set the stage for additional
studies regarding the reactions, which BorA5 can catalyze by monitoring
modifications to BorA5 ACP.

4.3 Materials and methods
4.3.1 Commercially purchased materials
All chemicals and antibiotics were purchased from Sigma Aldrich (St. Louis,
MO) unless otherwise noted. Restriction endonucleases and T4 DNA ligase were
purchased from New England Biolabs (Ipswich, MA). PCR primers were custom
synthesized from Integrated DNA Technologies (Coralville, IA). PCR reactions were
carried out with either the GC Rich PCR System from Roche (Basel, Switzerland) or
LA PCR Kit version 2.1 from Takara Bio INC (Madison, WI).

4.3.2 Construction of BorA5 E. coli expression constructs
Expression construct pJY50, which encodes BorA5 as an N-terminal His6
tagged protein was generated via three separate PCR reactions using cosmid Bor19B9
(107) that contains the borrelidin PKS gene cluster as the PCR template (Figure 35).
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Each individual PCR product was gel purified with use of Qiagen Gel Extraction Kit
(Valencia, CA) and sub cloned into pCR 8/GW/TOPO TA cloning vector, Invitrogen
(Carlsbad, CA) and subsequently transformed in One Shot Mach1 E. coli cells also
from Invitrogen. The first PCR product was generated as an NdeI/FspI fragment with
PCR primer pair BA5AF (5’- CAT ATG GTG ACC TCG GTC GGC CGC CG - 3’) +
BA5AR (5’ – AGT ACG CCC TTG CGC AGG GC – 3’). The PCR program
consisted of an initial hold for 2 minutes at 96 °C, followed by 30 cycles of 96 °C for
30 seconds, 58 °C for 30 seconds, and 72 °C for 1 minute. This was followed by a
final extension period at 72 °C for 5 minutes. The second PCR product was generated
with primer pair BA5BF (5’ – CAT ATG GCC CTG CGC AAG GGC GTA CT – 3’)
+ BA5BR (5’ – GGA TCC GAA ACC GAG CTG GT – 3’) as an NdeI/BamHI
fragment, where the NdeI restriction site was built into the primer overlapping the
natural FspI site of BorA5. The PCR program consisted of an initial hold for 2 minutes
at 94 °C followed by 30 cycles of 94 °C for 30 seconds, 56 °C for 60 seconds, and 72
°C for 2.5 minutes. This was followed by a final extension period at 72 °C for 10
minutes. The third PCR product was generated with primer pair BA5CF (5’ – CAT
ATG CTC GCC TCG CTG TCC GGC CCC – 3’) + BA5CR (5’ – AAG CTT TCA
CAG CAG GCC GGC GAG GTG CCC – 3’) as an NdeI/HindIII fragment, where the
NdeI restriction site was again built into the primer overlapping the natural BamHI site
of BorA5. The reverse primer contains the natural stop codon of BoA5 plus a built in
HindIII site for subsequent cloning steps. Each of the three inserts were verified by
plasmid sequencing with manufacturer supplied M13F and M13R primers, yielding
constructs pJY51A, pJY51B, and pJY51C respectively. The intact BorA5 coding
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sequence was generated by ligating each of the three fragments together as follows;
pJY51A was restricted with NdeI/FspI and the approximately 1.2 kb fragment was
ligated into pJY51B after restriction with NdeI/FspI. This intermediate plasmid
(pJY51AB) was transformed in E. coli and the plasmid purified as previously
described. Purified intermediate plasmid pJY51AB was restricted with NdeI/BamHI
and ligated into pJY51C after restriction with the same endonucleases to give
pJY51ABC. The compiled 6.5 kb fragment was then subsequently cloned from
pJY51ABC into pET 28 (Novagen) as an NdeI/HindIII fragment yielding pJY50.
Construct pJY55, which expresses just the ACP domain of BorA5 as an Nterminal His tagged protein was generated by PCR amplification followed by TOPO
TA cloning and subsequent cloning into the pET 28 expression plasmid as an
NdeI/HindIII fragment. The PCR product was generated with PCR primer pair
BA5ACPF (5’ – CAT ATG CTC GCC TCG CTG TCC GGC CCC – 3’) + BA5ACPR
(5’ – AAG CTT TCA CAG CAG GCC GGC GAG GTG CCC – 3’). The PCR
program consisted of an initial hold for 2 minutes at 94 °C, followed by 30 cycles of
94 °C for 30 seconds, 56 °C for 60 seconds, and 72 °C, for 1 minute. This was
followed by a final extension period at 72 °C for 10 minutes.
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Figure 35. PCR amplification and cloning of BorA5. Plasmids pJY51A/B/C were
individually generated by PCR amplification from cosmid Bor19B9. These constructs
were then subsequently restricted and ligated together. The entire 6.5 kb fragment
encoding BorA5 was ligated into pET28 as an NdeI/HindIII fragment yielding pJY50.

118

4.3.3 Expression and purification conditions for BorA5 recombinant proteins
BorA5 was over expressed and purified from E. coli by expression of pJY50 as
a N-terminal 6 His-tagged protein. Expression was carried out in either BL21 DE3
chemically competent cells (Invitrogen) or BAP1 cells. BAP1 E. coli cells are a
derivative of BL21 DE3 cells, which contain a chromosomally integrated copy of the
sfp gene encoding the requisite 4’-phosphopantetheinyl transferase, which allows for
posttranslational modification of the ACP domain to the holo form. BAP1 E. coli
cells were provided as a gift from Professor Chaitan Khosla’s laboratory, Stanford
University. The stand alone BorA5 ACP was over expressed and purified from E. coli
in the same manner by expression of pJY55 in BAP1 cells.
Overnight E. coli seed cultures harboring pJY50 or pJY55 were grown in LB
medium supplemented with 100 g/mL kanamycin at 37 °C with agitation. 1000 mL
LB medium cultures supplemented with 50 g/mL kanamycin were inoculated with 5%
(v/v) of the overnight seed culture and grown at 37 °C with agitation to an O.D of
approximately 0.6 (approximately 2.5 hours). Cultures were allowed to cool to room
temperature and expression was induced by the addition of isopropyl thio-Dgalactoside (IPTG) to a final concentration of 1.0 mM. Cultures for the expression of
BorA5 were allowed to grow for an additional 16 hours at room temperature with
agitation, while cultures for the expression of BorA5 ACP were allowed to grow for
an additional 3 hours at 37 °C. E. coli cells with either of the over expressed proteins
BorA5 or BorA5 ACP were harvested by centrifugation and either stored at -80°C or
immediately lysed for protein purification. His6-tagged protein was purified following
the protocol outlined in Qiagen’s QiAexpressionist handbook under native conditions
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with the following modifications. E. coli cells were re-suspended in 25 mL of
BugBuster Protein Extraction Reagent (Novagen). Cells were disrupted by sonication
and allowed to incubate on ice with slow agitation for at least 1 hour. The mixture
was then subjected to centrifugation and the soluble fraction (supernatant) was
incubated with 1 mL of Ni-NTA agarose (Qiagen) on ice with gentle agitation for at
least 1 hour. The mixture was then transferred to a Polyprep chromatography column
(BioRad) and allowed to equilibrate at 4°C. The cell free extract (CFE) was drained
and the Ni-NTA resin washed with 10 column volumes of wash buffer 1 (50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) followed by 10 column volumes
of wash buffer 2 (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0). His6tagged protein was eluted from the Ni-NTA resin with 3mL of elution buffer (50 mM
NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0). 5 separate elution fractions
were collected each containing between 500-600 µL total volume. Each of the 5
fractions along with the initial load, column flow through and the two column washes
were analyzed by SDS-PAGE gel electrophoresis using NuPAGE Novex 4-12% BisTris gels (Invitrogen). Expression and purification of the entire BorA5 module was
confirmed by the presence of a band over 200 kDa, the desired protein has a molecular
weight of approximately 230 kDa. Similarly, expression and purification of BA5 ACP
was confirmed by the presence of a band which was approximately 10 kDa, the
expected molecular weight of the recombinant protein is approximately 12 kDa. Both
desired proteins were further purified to homogeneity by size exclusion
chromatography using an AKTA FPLC System (GE Health care, formally Amersham
Biosciences) equipped with a Superdex GL 200 sizing column and a UV visible
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detector set at 280 nm. Fractions containing the His6-tagged protein were confirmed
by SDS PAGE gel electrophoresis and concentrated with Amicon Ultra Centrifuge
columns (Milipore) and stored at -80°C for future use.

4.3.4 In vitro acylation assay conditions
Due to the low quantity of recoverable BorA5 in the holo form (data not
shown), the apo form was used for used for in vitro enzyme assays. In vitro acylation
experiments consisted of three essential components a) acyl CoA substrates (malonyl,
and methylmalonyl) b) the apo form of BorA5 (to be utilized as a catalyst) and c) the
post translationally modified holo form of the stand alone ACP domain. The presence
of these components allowed for any covalent modifications of the ACP protein to be
monitored by subsequent mass spectrometric analysis.
Assays to probe whether or not the AT domain from an intact apo form of
BorA5 could act in trans and acylate the stand-alone ACP domain were carried out
under the following set of conditions. As negative controls the following reactions
which would not be expected to yield a covalently modified ACP protein were carried
out; a) ACP + malonyl CoA, b) ACP + methylmalonyl CoA, c) ACP + BorA5, d)
ACP + BorA5 + malonyl CoA. Contrastingly, the experimental reaction which would
be expected to result in the modification of BA5 ACP contained all of the following
components, ACP + BorA5 + methylmalonyl CoA. Each of these assays was carried
out with a 3:1 molar ratio of BorA5 ACP to BorA5 with 1mM of the respective acyl
CoA substrate in a buffer consisting of 200 mM NaH2PO4, 1 mM TCEP, 1 mM
EDTA, 20% glycerol, pH 7.4. Reactions were incubated at room temperature
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(approximately 25 °C) and aliquots were removed at t=0, 2, 4, 8 and 18 hours.

4.3.5 LC-MS analyses of BorA5 ACP acylation
Prior to LC-MS analysis each sample was dialyzed using Slide-A-Lyzer mini
dialysis units from Thermo Scientific (Rockford, IL) against 500 mL of a buffer
consisting of 100 mM NaH2PO4 and 100 mM NaCl at pH 7.4 at 4 °C for
approximately 2 hours. LC-MS analysis was performed using reverse phase HPLC on
an Agilent 1100 series LC (liquid chromatography) system coupled to a Bruker
MicroToF-Q mass spectrometer in the positive mode. LC separation was carried out
at an elevated temperature of 50 °C with a 5µm Discovery Bio Wide Pore C8 reverse
phase column (5 x 2.1 cm, Supelco), with a linear gradient system from solvent A
(water – 0.01% formic acid) to solvent B (acetonitrile – 0.01% formic acid) over 33
minutes at a flow rate of 0.3 mL/minute. In addition to acylation assays, the mass of
stand alone BorA5 ACP was also analyzed in this same manner.

4.4 Results
4.4.1 Expression and purification of BorA5 and BorA5 ACP
BorA5 as an N-terminal His6-tagged protein was over expressed in BL21 DE3
containing the construct pJY50. Expression of this construct under the above
described conditions presumably results in the generation of the apo form of the
protein (without the 4’-phosphopantetheine post translational modification), since this
E. coli strain lacks the sfp gene required for this modification. Protein expression was
observed by SDS-PAGE analysis, which demonstrated a significant band with an
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approximate molecular weight of 230 kDa, which is consistent with the expected
molecular weight based on the sequence of the cloned BorA5 open reading frame
(Figure 36). The Ni-NTA purified protein was further purified to homogeneity via
FPLC size exclusion chromatography. Repeated attempts to express BorA5 using
pJY50 in BAP1 cells (which contains a chromosomally integrated copy of the sfp
gene) and purify the holo form of this protein resulted in high levels of insoluble
proteins. All attempts to improve the solubility of the holo BorA5 by varying the
media, induction temperature and other culture conditions failed to result in higher
quantities of soluble protein.
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a)

M

L FT w1 w2 E1 E2 E3 E4 E5

His tagged BorA5
~230 kDa

~250 kDa

b)
c)

7 8 9
Purified apo
BorA5
~230 kDa

Figure 36. Expression and purification of apo BorA5. a) SDS PAGE gel of NiNTA resin purified protein (M-molecular weight marker, L-material loaded on NiNTA resin, FT-flow through, W1-W2 – washes, E1-E5 – elution fractions. b) Size
exclusion FPLC chromatogram of Ni-NTA purified protein, apo BorA5 eluted in
fractions 7-10. c) SDS PAGE gel of fractions containing partially purified protein
after size exclusion chromatography.
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Stand alone BorA5 ACP in the holo form was expressed and purified in an
analogous manner to the complete BorA5 module. BorA5 ACP as an N-terminal
His6-tagged protein was over expressed in BAP1 cells containing the construct pJY55.
Expression of this protein was detected as a significant band in SDS PAGE analysis,
with an approximate molecular weight of 12 kDa, this is consistent with the expected
mass based on the sequence of the cloned BorA5 ACP open reading frame (Figure
37). Ni-NTA purified protein was further purified via FPLC size exclusion
chromatography.
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a)

M

L FT w1 w2 E1 E2 E3 E4 E5

~15 kDa

His tagged
holo BorA5
ACP
~12 kDa

~10 kDa

b)

c)

18 19

Purified holo
BorA5 ACP
~12 kDa

Figure 37. Expression and purification of holo BorA5 ACP. a) SDS PAGE gel of
Ni-NTA resin purified protein (M-molecular weight marker, L-material loaded on NiNTA resin, FT-flow through, W1-W2 – washes, E1-E5 – elution fractions. b) Size
exclusion FPLC chromatogram of Ni-NTA purified protein, holo BorA5 ACP eluted
in factions 7-10. c) SDS PAGE gel of fractions containing partially purified protein
after size exclusion chromatography.
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4.4.2 LC-MS analysis of holo BorA5 ACP domain
Mass spectrometric analysis of BorA5 ACP domain was completed to confirm
the identity of the purified 12 kDa protein (Figure 38).

Figure 38. Positive mode mass analysis of BorA5 ACP. a) Selected ion mass
spectrum of the LC chromatogram elution at approximately 16 minutes. Each mass
represents a different charge state of the multiply charged protein molecule. b) Charge
deconvoluted mass spectrum of (a), BorA5 ACP is identified by a mass value of
11498.4 Da.

BorA5 ACP was expressed in BAP1 E. coli cells, in an attempt to generate the holo
form (with the 4’-phosphopantetheine group covalently attached) of the protein, which
is required for the covalent attachment of polyketide intermediates and acyl group
extender units. The predicted mass of the recombinant protein with the N-terminal
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His6 tag in the holo form is 11497.6 Da and when analyzed in the positive mode, has a
mass of 11498.6 Da. The observed mass of 11498.4 Da (Figure 37b) is within 10 ppm
of the calculated theoretical mass. This result is consistent with the expression and
purification of the target protein, holo BorA5 ACP.

4.4.2 LC-MS analysis of apo BorA5 in vitro acylation activity
PKS proteins which contain ACP domains requires posttranslational
modification (with the phosphopantetheine arm) to be active and capable of accepting
polyketide extender units. Because the ACP domain of the complete and intact apo
BorA5 module lacks this modification it was sought to examine if the remainder of the
domains within the protein retained activity. Initially, work began by assessing if the
AT domain of apo BorA5 was capable of acylating the stand-alone holo BorA5 ACP
protein when combined in trans. The two purified proteins were coincubated in the
presence of the natural extender unit for this module, methylmalonyl CoA (Figure 39).
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Figure 39. Proposed reaction between apo BorA5 and stand alone holo BorA5
ACP domain in trans with one another. The ACP domain of apo BorA5 does not
possess the posttranslational modification required to accept the AT domain selected
extender unit. Apo BorA5 along with the specific BorA5 AT domain extender unit
(methylmalonyl CoA) was incubated along with the BorA5 ACP in the holo form to
examine if the AT and ACP domains could facilitate acyl group transfer.
With the ability to identify the BorA5 ACP protein by LC-MS analysis (Figure
38), covalent modifications of the protein can be observed by the appropriate and
predicted increases in mass for specific acyl groups or polyketide intermediates bound
to the protein. Indeed, overnight incubations with apo BorA5, holo BorA5 ACP, and
methylmalonyl CoA resulted in a new mass of 11598 Da, which is consistent with
covalent modification of the stand-alone ACP domain with methylmalonate (Figure
40).
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Figure 40. Positive mode mass analysis of an overnight incubation of apo BorA5
with holo BorA5 ACP and methylmalonyl CoA. a) Selected ion mass spectrum of
the LC chromatogram elution at approximately 16 minutes. b) Charge deconvoluted
mass spectrum of (a) resulted in two m/z values of interest. Holo BorA5 ACP is
identified by an m/z value of 11498.5 while a new mass of 11598.5 correlates to the
mass of the ACP domain acylated with methylmalonate.
Incubations devoid of either apo BorA5, BorA5 ACP or methylmalonyl CoA
as well as incubations utilizing malonyl CoA (not the cognate substrate for BorA5 AT)
resulted in no observed covalent modification of the holo BorA5 ACP domain.
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4.5 Discussion
4.5.1 Trans in vitro acylation of stand alone holo BorA5 ACP
Based on published work with module 3 of the DEBS PKS (108) and PKSA
(111) which is involved in the biosynthesis of the environmental carcinogen aflatoxin
B1, the ability of the AT domain from the intact apo BorA5 module to acylate a
separate ACP domain protein specifically with methylmalonyl CoA, is consistent with
the notion that multi-domain PKS proteins can be reconstituted as separate proteins in
vitro, while retaining catalytic activity. In both of these published examples of multi
domain PKS proteins being reconstituted as multiple proteins in vitro while retaining
enzymatic activity, each of the respective domains (such as KS, AT, ACP) were only
present in one form, either as a single stand-alone protein or in combination with other
catalytic domains. Contrastingly, the results shown here indicate that even when an
intact module including the ACP domain in the apo form is combined in trans with a
stand alone holo ACP domain, acyl group transfer from the AT domain of the intact
module to the holo ACP domain is possible (Figure 40). The ability of the single
domain holo ACP protein to accept an acyl group substrate from an AT that is part of
an intact modular protein may signify the inherent specificity of an ACP domain to
interact properly with its cognate AT, as well as the versatility of the
phosphopantetheine arm of an ACP domain to accept the extender unit acyl group
from the AT domain. The fact that no covalent modifications of BorA5 ACP were
observed when malonyl CoA was utilized may reflect a reinforcement of the strict
substrate specificity of extension module AT domains for specific extender units (79).
Conversely, the inability to detect malonyl BorA5 ACP may reflect the acylation of
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the AT domain with malonyl CoA, followed by the rapid hydrolysis of the malonate
acyl group before transfer to the ACP can occur. The work in the DEBS PKS system
described in chapter 3, demonstrates that there are significant acylation and hydrolysis
reaction rates for AT domains and that transfer to an ACP can be a limiting factor.
The intriguing observation of trans acylation of a stand-alone ACP domain protein by
an AT domain contained within an entire intact module represents a potential key step
towards understanding the BorA5 iterative module. In principle, the ability to monitor
the reactions which BorA5 catalyzes by MS analysis of a stand alone ACP domain
using either apo BorA5 or dissected components of the module may aid in elucidating
the specific mechanism of iteration as well as provide insights into the potential
substrate flexibility of this module. However this approach is not without some
drawbacks. Under the optimized conditions, that were developed, the acylation of
holo BorA5 ACP was only observed after overnight (> 16 hour) incubations and
resulted in approximately 50% conversion to the acylated form. Attempts to increase
the efficiency of acylation were attempted by adjusting the ratio of the apo BorA5
catalyst to the holo BorA5 ACP substrate, but did not result in any significant change
in acylation efficiency. Other attempts to increase the efficiency of acyl group transfer
from the AT to the ACP domain included expressing other forms of the BorA5 AT
domain (KS-AT, AT, KS-AT-DH-ER-KR), however these expression constructs
either resulted in poor expression or insoluble proteins.
In conclusion, it has been shown that in vitro reconstitution of the apo form of
BorA5 from the borellidin PKS is capable of acylating its cognate ACP in trans when
it is a stand-alone protein. Based on the preliminary observations of this study, this
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trans acylation reaction of the separate ACP protein is not a rapid or efficient process.
This highlights the innate specificity that cognate PKS domains have for one another.
These observations suggests that future studies of BorA5 to better understand the
iterative nature and the potential substrate flexibility of this module can be approached
by monitoring modifications to the stand-alone BorA5 ACP domain when coincubated
with either apo BorA5 or dissected components of the module.
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5. Conclusions and recommendations for future work

The work presented in this thesis describes the utilization of a matched
docking domain pair from the phoslactomycin PKS system to functionally dissect
single multimodular polypeptides from both the pikromycin and erythromycin PKSs
into separate proteins. Both of the examples from the pikromycin and erythromycin
systems, where the natural intrapolypeptide linkers between neighboring modules was
replaced with the matched docking domain pair resulted in 50% polyketide production
compared to the intact un-separated intact control experiments. In addition to the
significant retention of polyketide production which these dissections yielded, the
results from the separation of DEBS1-TE has provided significant insights into the
dynamics of AT domain acyl group loading and hydrolysis as well as new insights
into the rate of transfer from the AT to the ACP domain for different acyl groups.

Conclusion 1
Experiments dissecting PikAI and DEBS1-TE, multimodular polypeptides
from the pikromycin and erythromycin PKS have provided additional in vivo
examples that multimodular PKS can be separated into individual modules by
replacing the intrapolypeptide linker with a heterologous DD pair, in this work a
docking domain pair from the phoslactomycin PKS. Additionally this work has
specifically demonstrated that docking domains are required for module-to-module
interaction and that simply separating multimodular PKS proteins without the proper
docking interactions results in a tremendous drop in polyketide production. These
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observations demonstrate for the first time that the separation of these complex
multifunctional proteins can lead to only a modest decrease in the overall production
of the final polyketide product compared to the intact protein.

Conclusion 2
In the case of PikAI from the pikromycin system, it has been shown that the
efficiency of in vivo utilization of the NAC-thioester mimic, (of the natural diketidie
intermediate) presented to the KS of module 2 can vary depending on the context of
the feeding experiment. Depending on whether the preceding module was covalently
linked, separated with docking domains, or removed entirely, resulted in significantly
differing levels of incorporation into the final product. The results of this work
demonstrate that accessing internally linked modules of multimodular PKS proteins
with synthetic intermediates is very inefficient but can be improved significantly by
removal of the preceding modules and expression of the internal module with an Nterminal docking domain. The ability to access internal PKS modules efficiently adds
another tool to precursor-directed biosynthetic efforts, which can lead to the
production of new antibiotics with useful properties.

Conclusion 3
Separation of the trimodular PKS polypeptide DEBS1-TE, at the modulemodule junctions with a matched docking domain pair from the phoslactomycin PKS
results in approximately 50% triketide lactone production compared to intact DEBS1TE. Dissection of DEBS1-TE at the loading domain-module 1 junction results in a
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dramatic shift in starter unit incorporation, with a predominance in the isobutyratederived triketide lactone. In vitro data with the DEBS ATL-ACPL has shown
isobutyrate being preferentially loaded onto the AT domain versus propionate.
However propionate being kinetically favored in the subsequent passage step of acyl
groups from the AT to the ACP domain. Under wild type fermentation conditions
when DEBS1 is an intact protein, propionate is the kinetic product presented to the KS
domain of module 1 by ACPL. However when the system is dissected at the loading
domain module 1 junction, the efficiency of acyl group transfer between ACPL and the
KS of module 1 diminishes, allowing the dynamics of acyl group loading, hydrolysis
and domain transfer to equilibrate with isobutyrate predominating on the ACP domain.
By slowing down the natural biosynthetic process between DEBS ATL-ACPL and the
KS of module 1, insights into the dynamics of acyl group loading, hydrolysis and
transfer between ATL and ACPL have been gained.

Future work
Given the complexity of the compiled data presented in this thesis, which
indicates that isobutyrate loaded on the AT domain, is favored over propionate but that
propionate is kinetically favored on the ACP domain. Future work will consist of
mass spectrometric analysis of the specific peptides containing the active site serine
residue of the AT domain, where acyl groups are covalently bound, as well as the
serine residue of the ACP domain where the phosphopantetheine moiety is attached.
Incubating the recombinant DEBS ATL-ACPL protein expressed and purified from E.
coli with both propionyl and isobutyryl CoA competing substrates, followed by
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proteolytic digestion and mass spec analysis, will yield information regarding which
substrates are bound to the AT and ACP domains and in what proportion they exist
relative to one another. Direct identification of which acyl group predominates on the
AT and ACP domains under competition conditions will help support the current 14C
labeling data.

Conclusion 4
In vitro work with the iterative BorA5 PKS module from the borrelidin PKS
has shown that the AT domain an intact and complete module in the apo form, is
capable acylating a stand alone form of its cognate ACP in trans with methylmalonyl
CoA, when the ACP domain is in the holo form. This example of reconstituting
enzymatic activity by expressing individual domains of PKS modules as discrete
proteins is consistent with previously published work with other PKS systems. This
preliminary work on BorA5 is the first observation that an AT domain from an intact
and complete module can act in trans, acylating a separate stand alone ACP domain
protein and has laid the groundwork for future work on this iterative PKS module.

Future work
Future work on the iterative BorA5 module should be focused on optimizing
the acylation reaction of the stand alone holo BorA5 ACP protein. Perhaps the
presence of the other domains (DH, ER, KR, apo ACP) may hinder the trans acylation
reaction and it is possible that removal of these domains will increase the accessibility
of the holo ACP phosphopantetheine arm to the acyl group bound to the AT domain.
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Despite the difficulties in generating soluble proteins thus far from expression
constructs aimed at truncating BorA5 perhaps alternate expression constructs or
expression conditions may result in improved results.
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